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I 
Abstract  
Background: Human mesenchymal stem cells (MSC) interact with numerous immune cells that 
can promote regenerative processes and inhibit inflammatory responses. It is hypothesised that 
the crosstalk between human umbilical cord perivascular cells (HUCPV; an alternative source of 
MSC) and peripheral blood mononuclear cells (PBMC)/macrophages could be influenced by 
degradable magnesium (Mg) and its alloy (Mg-10Gd; 10 weight % gadolinium). Moreover, the 
mechanisms of Mg-based material-modulated immune reactions—macrophage functions and 
subsequent bone formation—still need to be investigated. Methods: For analysis of the 
correlations between paracrine signalling and specific cellular behaviour during the initial host 
response to Mg, two in vitro indirect coculture systems of HUCPV and PBMC were developed in 7 
days: (i) transwell (TW) and (ii) conditioned media (CM). In the subsequent 7-14 days, for analysis 
of the roles of Mg/Mg-10Gd on secretions of macrophages and their effects on pro-osteogenic 
activity, a direct coculture system of HUCPV and macrophages was established. Results: Cell 
growth was not significantly influenced by Mg (TW, CM and direct coculture system) or Mg-10Gd 
(direct coculture system). In the TW system, when HUCPV were cultured with degradable Mg, 
moderate inflammation (i.e., decreased secretion of proinflammatory interleukin 1 beta (IL1β), IL2, 
tumour necrosis factor alpha (TNFα), and interferon gamma (IFNγ) and anti-inflammatory IL4, IL5, 
IL10, IL13, and 1 receptor antagonist (IL1RA) and granulocyte colony stimulating factor (G-CSF)), 
as well as an increased pro-healing M2 macrophage phenotype, was observed. Moreover, when 
PBMC were cultured with degradable Mg, the expression of migration/wound healing-related 
cytokines (IL8, granulocyte-macrophage colony-stimulating factor (GM-CSF), monocyte 
chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein (MIP)-1α/β) increased, 
accompanied by an increased migration of HUCPV (cell scratch assay). In addition, an increased 
pro-osteogenic potential was demonstrated via an increase in osteoblastic markers (e.g., alkaline 
phosphatase (ALP) activity, specific gene expression and cytokine release). In the CM system, the 
percentage of the M2 macrophage phenotype could only be increased by HUCPV and/or Mg. In 
the direct coculture system, Mg and Mg-10Gd were found to modulate osteogenic differentiation 
through oncostatin M (OSM) and glycoprotein 130 (gp130). Furthermore, both materials 
upregulated the gene expression of bone morphogenetic protein 6 (BMP6) in macrophages and of 
bone morphogenetic protein receptor type 1A and 2 (BMPR1A/2) and mothers against 
decapentaplegic homologue (Smad) 1/4/5 in cocultured MSC. In addition, both treatments could 
reduce the secretion of TNFα and IL1β in macrophages and cocultures, which might act 
synergistically in providing a pro-osteogenic microenvironment. Conclusion: These results 
collectively imply that Mg possesses osteoimmunomodulatory properties. This study also highlights 
the roles of material-activated macrophages in pro-osteogenic activity via the OSM/gp130 and 
Smad-related signalling pathways. Moreover, these findings provide insight into developing Mg-
based bone substitute biomaterials capable of desired immune reactions (e.g., tissue regenerative 
M2 macrophage phenotype) and therapeutic applications using interactions of immune cells and 
MSC for bone regeneration.
 
II 
Zusammenfassung 
Motivation: Humane mesenchymale Stammzellen (MSC) interagieren mit zahlreichen 
Immunzellen, die Regenerationsprozesse fördern und Entzündungsreaktionen hemmen können. 
Es wird angenommen, dass die Interaktionen zwischen perivaskulären Zellen der menschlichen 
Nabelschnur (HUCPV; eine alternative Quelle für MSC) und mononukleären Zellen des peripheren 
Blutes (PBMC)/Makrophagen durch abbaubares Magnesium (Mg) und seine Legierung (Mg-10Gd; 
10 Gew .-% Gadolinium) beeinflusst werden. Die Mechanismen der Wirkung von Mg basierten 
Materialien, die die Immunreaktion modulieren, die Makrophagenfunktionen und die 
anschließende Knochenbildung müssen jedoch noch aufgeklärt werden. Methoden: Zwei 
indirekte in-vitro-Kokultursysteme von HUCPV und PBMC wurden entwickelt, um den 
Zusammenhang zwischen parakrinen Signalen und spezifischem zellulärem Verhalten während 
der anfänglichen Reaktion (7 Tage) des potentiellen Implantatempfängers unter Mg Exposition zu 
untersuchen: (i) Transwell (TW) und (ii) konditionierte Medien (CM). Des weiteren wurde ein 
direktes Kokultursystem von HUCPV und Makrophagen etabliert, um die Rolle von Mg bzw. Mg-
10Gd auf die Sekretion von Makrophagen und ihre Auswirkungen auf die proosteogene Aktivität 
(7-14 Tage) zu analysieren. Ergebnisse: Das Zellwachstum in keinem der getesteten Systeme 
wurde durch Mg und Mg-10Gd signifikant beeinflusst. Im transwell coculture-System, das heißt 
wenn HUCPV mit abbaubarem Mg kultiviert wurden, konnte eine gemäßigtere 
Entzündungsreaktion über die geringere Sekretion von pro-inflammatorischen Zytokinen und 
entzündungshemmenden Zytokinen nachgewiesen werden. Darüberhinaus wurde ein erhöhter 
anti-inflammatorischer M2-Makrophagen-Phänotyp beobachtet. Wenn PBMC mit abbaubarem Mg 
kultiviert wurden, erhöhte sich außerdem die Expression von solchen Zytokinen, die mit der 
Wundheilung verbunden sind, was mit einer erhöhten Einwanderung von Stammzellen einherging. 
Zusätzlich wurde ein erhöhtes proosteogenes Potential durch eine gesteigerte Expression und 
Aktivität osteoblastischer Marker (z.B. alkalische Phosphatase (ALP)) gezeigt. Im CM-System 
konnte der Prozentsatz des Phänotyps der M2-Makrophagen nur durch HUCPV und/oder Mg 
erhöht werden. Hinsichtlich der Darstellung der zugrunde liegenden Wirkmechanismen wurde 
anhand des direkten Kokultursystems unter Mg Exposition eine Beteiligung der Onkostatin M 
(OSM) und Glykoprotein 130 (gp130) basierten Signalwege an der osteogenen Differenzierung 
nachgewiesen; Darüber hinaus regulierten beide Materialien die Genexpression von 
knochenmorphogenetischem Protein 6 (BMP6) in Makrophagen, von knochenmorphogenetischem 
Proteinrezeptor Typ 1A und 2 (BMPR1A/2) und den Smad-homolog Signalweg auf parakrine Weise 
in kokultivierten MSC. Zusätzlich reduzierten beide Materialien die Sekretion von TNFα und IL1β 
in Makrophagen und Kokulturen, was synergistisch für eine proosteogene Mikroumgebung sorgen 
könnte. Fazit: Diese Ergebnisse implizieren, dass Mg komplexe osteoimmunmodulatorische 
Eigenschaften besitzt. Diese Studie beleuchtet insbesondere die Auswirkungen auf die 
interzelluläre Kommunikation von Mg-aktivierten Makrophagen für die proosteogenen Entwicklung 
von Stammzellen. Die Wirkung wird auf einen Einfluss über den OSM/gp130- und Smad-
bezogenen Signalweg beschrieben. Insbesondere durch den nachgewiesenen erhöhten Anteil der 
geweberegenerierenden M2 Makrophagen wird ein neuer Aspekt der therapeutischen Anwendung 
für die Knochenregeneration aufgezeigt.
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1. Introduction 
Fracture is the most common major organ trauma in humans, and approximately 10% cannot 
be properly cured [1]. The incidence of fractures increases dramatically from all causes at many 
skeletal sites [2]. Furthermore, the correlation between the incidence of fracture and various 
diseases, including chronic kidney disease [3, 4], coeliac disease [5], chronic liver disease [6], 
is a growing concern. Therefore, improvement of fracture healing is important for clinical 
practice. 
Fixation biomaterials have emerged as a classical treatment to recover mobility and support 
healing after fractures. As proposed by D.F. Williams, “A biomaterial is a substance that has 
been engineered to take a form which, alone or as part of a complex system, is used to direct, 
by control of interactions with components of the living system, the course of any therapeutic 
or diagnostic procedure, in human or veterinary medicine” [7]. Desirable biomaterials are 
nontoxic and show good strength, biocompatibility and self-assembly. In recent decades, 
biomaterials have become more biocompatible, and demand has increased. Among the 
biomaterials, titanium (Ti) and its alloys are preferred as orthopaedic materials [8, 9]. However, 
in addition to the high expense, Ti and its alloys can cause implant failure and allergies to metal 
debris [10]. Recent studies on orthopaedic materials have concentrated on materials dissolving 
in physiological environments (body fluid) while stimulating bone regeneration. For example, 
magnesium (Mg) and its alloys have been used as bioabsorbable materials for medical implants 
and show promising degradation behaviour [11], exhibiting an appropriate inflammatory 
response [12, 13] while improving tissue healing and bone regeneration [14]. 
After implantation into fracture sites (Fig. 1), a sequence of events occurs at the surface of the 
biomaterials. 
1) A layer of proteins from the surrounding microenvironment is adsorbed onto the 
material surface, forming a surface matrix and conditioning all further steps. Surface-
modified biomaterials are continuously developed to influence protein absorption [15, 
16] and subsequent bone formation [17, 18]. 
2) An immune response, such as neutrophil activation, occurs on fracture sites, followed 
by macrophage activation, foreign body giant cell (FBGC) production and formation of 
granulation tissue. 
3) These cells release chemoattractants and cytokines to recruit tissue-repairing cells, 
such as fibroblasts and mesenchymal stem cells (MSC), to injury sites to deposit 
collagen matrix and form a fibrous encapsulation. 
The implant-induced immune reactions could also contribute to the cellular interaction and 
differentiation of bone-forming cells (e.g., MSC, osteoblasts and osteoclasts). Regarding the 
complexity of processes 2) and 3), more studies about the mechanism of the immune response 
following biologically Mg-based biomaterial implantation are still required. Hence, the current 
research examines the effects of immune cells (peripheral blood mononuclear cells 
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(PBMC)/macrophages) and MSC, which are two vital factors participating in the immune 
response of fracture healing. 
Fig. 1 Biological responses following biomaterial implantation. Adapted from [19]. Reused by 
permission from Elsevier Publishers, Ltd.: Materials Today.  
First, the effects of pure Mg on indirect interactions (cell-cell noncontact) of 
PBMC/macrophages and mesenchymal stem cells (MSC) were evaluated. Parameters such 
as released cytokine levels, macrophage polarization, migratory ability and osteoblastogenesis 
potential of MSC were measured. Second, the effects of Mg or Mg-10Gd (Gd; gadolinium, 10 
weight %) on direct communication (cell-cell contact) between MSC and macrophages involved 
in osteogenic activity were also investigated. The possible signalling factors, such as 
immunoregulatory factors (oncostatin M (OSM) and interleukin 6 (IL6)), growth factors (bone 
morphogenetic protein (BMP)) and proinflammatory cytokines (tumour necrosis factor alpha 
(TNFα) and interleukin 1 beta (IL1β)) were analysed. The underlying signalling pathways, such 
as OSM/IL6-gp130 (glycoprotein 130) and BMP/Smad (mothers against decapentaplegic 
homologue), mediating the osteogenic activity of MSC when interacting with macrophages 
and/or Mg-based biomaterials were investigated.  
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2. The state of the art 
2.1.  Magnesium (Mg) in biology 
Mg is the fourth most abundant mineral in the body. An adult body contains approximately 22 
to 26 g of Mg, with 60% found in bone (one-third on the surface of hydroxyapatite), 20% in 
muscle, and the rest in soft tissue [20]. Mg ions act as cofactors or complexes with more than 
300 enzymes and proteins that regulate several and various biochemical reactions or metabolic 
processes, such as deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and protein synthesis 
[21]. Importantly, Mg ions can also bind to adenosine triphosphate (ATP) to form the Mg-ATP 
complex [22]. This complex acts as an energy source and plays a role in intracellular energy 
production and regulation of neuromuscular activity in the body [23, 24]. In addition, Mg is often 
referred to as a calcium (Ca) antagonist due to, for example, its role in muscle 
contraction/relaxation. This in muscle contraction/relaxation has been proven to inhibit Ca influx 
via the blockage of Ca channels [25] and the N-methyl-d-aspartate (NMDA) receptor [26]. 
Mg has been shown to play multiple and important roles in the immune system. Mg has been 
associated with various clinical symptoms, including inflammation [27, 28] and cardiovascular 
pathologies [29, 30]. Magnesium deficiency is a mechanism associated with increased 
inflammation and oxidative pathology [31, 32]. As shown in Table 1, Mg regulates the immune 
reaction because it can, for instance, reduce the harm caused by reactive oxygen species (ROS) 
[33]. In vitro studies also demonstrated a direct role of MgSO4 in decreasing the production of 
proinflammatory cytokines [34], as well as mediating anti-inflammatory effects by activating the 
phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway [35]. A mechanism of 
action study from B Rochelson et al. showed that Mg ions could also reduce nuclear factor 
kappa-light-chain-enhancer of activated B cell (NFκB) nuclear translocation and protect 
cytoplasmic nuclear factor of kappa light polypeptide gene enhancer in B-cell inhibitor, alpha 
(IκBα; an NFκB inhibitor) from degradation in lipopolysaccharide (LPS)-treated human umbilical 
vein endothelial cells (HUVECs) [36]. In contrast, Mg supplementation or Mg-rich conditions 
are known to exert an anti-inflammatory action. For instance, in rats, increasing Mg 
concentrations decreased the inflammatory response, while reducing extracellular Mg resulted 
in macrophage activation and secretion of inflammatory molecules [31]. In vivo investigation of 
the macrophage response to Mg ions was also carried out and indicated that Mg salts could 
inhibit inflammation and further suppress thrombus formation [37]. L-type Ca channels were 
shown to be involved in magnesium supplementation, reducing the production of 
proinflammatory cytokines, which increase due to NFκB [38].  
In addition, an increasing number of studies have been conducted on the roles of Mg in bone 
metabolic activity (Table 1). Numerous reports over recent years have demonstrated that Mg 
ions can stimulate osteogenic differentiation of MSC and bone regeneration in vitro [39, 40]. 
Furthermore, Mg appears to influence the activities of osteoblasts and osteoclasts [41]. Mg 
deficiency is a major contributing factor in patients with established osteoporosis, with low 
vitamin D and parathyroid hormone (PTH) levels [42]. Another population-based study showed 
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that Mg therapy could contribute to preventing fractures and lead to a clear increase in bone 
density in menopausal women [43]. 
Table 1 The roles of Mg and its deficiency/supplementation in biology. 
Effect Mechanism Model Reference 
Cellular/molecular biology 
Cofactor of or complex with 
more than 300 enzymes and 
proteins 
Human [21] 
Intracellular energy production 
by Mg-ATP complex 
Human [22-24] 
Muscle contraction/relaxation by 
influencing Ca influx and NMDA 
receptor 
Human 
[25, 26, 
44] 
Mg 
deficiency/supplementation 
and inflammation 
L-type Ca channels and 
cytosolic Ca activation 
Human 
[27, 28, 
31, 32, 34] 
Cardiovascular pathologies 
through inflammatory/pro-
oxidant events 
Rodent [29, 30] 
Reactive oxygen species (ROS)  Rodent [33]. 
Proinflammatory cytokines Human [34] 
(PI3K)/protein kinase B (Akt) 
pathway  
Rodent [35] 
NFκB signalling HUVECs [36] 
Mg 
deficiency/supplementation 
and bone metabolic activity 
MSC differentiation 
Human 
cells 
[39] 
Inhibition of pathways of 
macrophages and osteoclastic 
activities 
Rodent 
cell lines 
[40] 
Osteoblast and osteoclast 
Rodent 
cell lines 
[40, 41] 
Osteoporosis, vitamin D and 
PTH 
Human [42] 
Bone density Human [43] 
2.2.  Mg as a biomaterial 
The use of Mg and its alloys in cardiovascular and orthopaedic applications is not a new concept. 
In the past hundreds of years, Mg and its alloys were reported to be more or less effective.  
As shown in Table 2, the history of bioresorbable and biodegradable Mg and its alloys as 
implants in cardiovascular applications started in the year of 1878, when Huse proposed that 
Mg wire could end the bleeding in vessels [45]. In 1900, Payr designed a tubular, thin-walled 
Mg cylinders as connectors for vessels [46]. Engineered as rings [47], clips and staples [48], 
as well as wires [49], Mg and its alloys, were considered attractive implants for the closure of 
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tissue vessels and deep wound. Mg wires were used in a rabbit model by Seelig et al. in 1924; 
They confirmed Mg was a suitable biomaterials for suture and ligature [50]. In the early years 
of the 2000s, the properties and influences on coronary arteries of two materials, AE21 
(containing about 2 % aluminium and 1 % rare earth elements) and WE43 (containing about 
4 % yttrium, 3 % neodymium and less than 1 % zirconium), have been assessed [51-53]. In 
2005, Zartner et al. described the first successful implantation of Mg stent into the left 
pulmonary artery of a preterm baby, highlighting advantage of the resorbable property of Mg-
based biomaterials (especially in growing paediatric patients) [54]. Afterwards, several 
generations of a successful absorbable metal stents (AMS) were produced from Mg-based 
alloys, such as AMS, AMS INSIGHT, PROGRESS-AMS and BIOCOLVE-1 DREAMS (products 
from BIOTRONIK AG, Berlin, Germany). The clinical use has shown high biocompatibilities (no 
blood or vessel toxicity to implanted stents) [55-61]. Especially, the Mg stents could degrade 
safely in 4 months and present good coronary angiography result [54, 55, 59]. 
Table 2 The history of Mg and its alloys in cardiovascular applications. Summarised by previous 
works [44, 62-64].
Year Mg/its alloys Application Model Reference 
1878 Mg wire Stop bleeding vessels Human [45] 
1900 
Tubular, thin-walled 
Mg cylinders 
Connectors for vessel 
anastomosis 
Human and 
animals 
[44] 
1910 Mg rings 
Extravascular sutures of 
vessels 
Dogs [47] 
1917 
Mg and its alloys as 
clips and staples 
Closing tissue vessels, 
such as brain 
Dogs [48] 
1924 Mg wires Suture and ligature Rabbits [50] 
1951 Mg and Mg-Al wires 
Double-coiled wires in 
aortas 
Dogs [49] 
2003 AE21 stents Cardiovascular implant Domestic pigs [51] 
2006-2007 WE43 stents 
Coronary arteries 
implant 
Pigs [52, 53] 
2008-2009 AMS 
Coronary arteries 
implant 
Pigs [65, 66] 
2005-2013 
AMS 
Blood vessels implants Human 
[55-57] 
AMS INSIGHT [58] 
PROGRESS-AMS [59, 60] 
BIOCOLVE-1 
DREAMS 
[61] 
In accordance with the importance of Mg in bone structural development, Mg is frequently 
explored as one of the most promising orthopaedic implants . Bioresorbable Mg-based implants 
have mechanical properties similar to those of bone and could thus reduce implantation failure 
from stress shielding [16]. As shown in Table 3, early in the 1900s, Lambotte, Verbrugge and 
McBride reported machined Mg and its alloys in plates, sheets, screws and nails for transfixion 
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and/or bone tissue fracture support, resulting in human osteosynthesis activity [44, 67, 68]. As 
mentioned in [62], in 1940 and 1948, Mg and its alloys were further placed in fracture sites, and 
bone synthesis and formation were measured. Since then, more than 20 different alloys of bare 
metal (BM) Mg implants have already been tested in bone tissues and animal models [64]. 
Then, a Mg alloy, MgYREZr (Mg-yttrium-rare earth-zirconium alloy), was reported to achieve 
good compatibility and osteoconductivity without acute or chronic toxicity [69], leading to the 
approval of the MAGNEZIX® screw (Syntellix AG, Hannover, Germany) in medical applications 
in Europe [70]. 
Table 3 The history of Mg and its alloys in orthopaedic applications. 
Year Mg/its alloys Application Model Reference 
1909-1937 
Mg plates, sheets 
and screws 
Bone synthesis Human [44] 
1938 
Mg alloys as 
screws and nails 
Transfixion in the 
fracture 
Human and dogs [67, 68] 
1940 Mg sheets 
Bone synthesis in 
fractures 
Human and 
rabbits 
[62] 
1948 
Mg-Cd alloy as 
plates and screws 
Formation of 
callus bone 
Human [62] 
~2014 Mg alloys 
Bone synthesis in 
fractures 
Animals [64] 
2014-2017 
MgYREZr as 
screws 
Transfixion in the 
fracture 
Rabbits and 
human 
[69, 71] 
2014 
MAGNEZIX® 
screw 
Bone synthesis in 
fractures 
Human [70] 
2.3.  Fracture healing and interactions of MSC-immune cells 
2.3.1.  Bone composition 
Bone is the hardest connective tissue in the body and consists of 50% water [72]. During bone 
growth, bone relies on the blood supply as a fundamental source of energy equivalents and 
hormones to regulate the growth process. The basic composition of bone is cells and related 
matrix (Fig. 2).  
There are four main types of cells in bone tissues: osteogenic cells (stem cells), osteoblasts, 
osteoclasts and osteocytes. Osteoclasts are derived from haematopoietic progenitors (e.g., 
monocytes and macrophages) in the bone marrow. They are formed by fusion of precursor cells 
and are thus multinucleated. The three other types of cells are derived from the mesenchymal 
lineage. Human MSC are multipotent stem cells and form heterogeneous populations that can 
be found in different organs and tissues [73]. MSC can differentiate into several specific cell 
types and produce cytokines and soluble factors. Moreover, MSC can migrate to the damage 
sites and show potent anti-inflammatory and immunomodulatory effects via released mediators 
[73, 74]. Osteoblasts are derived from osteoprogenitor cells and synthesize bone (i.e., collagen 
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matrix and calcium salts). Osteocytes are mature bone cells (formed from osteoblasts) 
entrapped in the matrix and involved in the maintenance of bone. Osteoclasts degrade the bone 
matrix and resorb bone tissue. Osteoblasts and osteoclasts form and degrade bone tissues 
and regulate bone turnover. 
Fig. 2 The basic composition of bone. Osteoclasts, osteogenic cells, osteoblasts and 
osteocytes exhibit different functions and are found in different locations in bone. Osteogenic 
cells can be found in the deep layers of the periosteum and the bone marrow. Osteoblasts are 
located in growing parts of the bone (including the periosteum and endosteum). Osteoblasts 
trapped in the matrix that they secrete are called osteocytes. Osteoclasts are on the bone 
surfaces and at sites of old or injured bone. 
2.3.2.  Fracture healing 
Fracture healing involves three main stages: inflammation, tissue repair, and remodelling 
phases, as indicated in Fig. 3. 
The three main phases in fracture healing are as follows: 
1) Inflammation (0-5 days). Haematoma formation with inflammatory reactions 
(polymorphonuclear leukocytes (PMNs, also called granular leukocyte, granulocytes), 
monocytes/macrophages, T cells, B cells). PMNs consist of neutrophils (50%-70%), 
eosinophils (2-4%) and basophils (0.5-1%) [84]. Neutrophils have a relatively short life and 
can only circulate for days [85]. Normally, monocytes live for several days, but 
macrophages can survive up to months [86]. 
2) Tissue repair (5-21 days). Close to the fracture lines, granulation tissue (new 
connective tissue and microscopic blood vessels) will form. Chondrocytes, arising from 
mesenchymal stem cells, form extracellular matrix until all granulation and fibrous tissues 
are replaced by cartilage [75]. Then, the chondrocytes undergo mineralization. With soft 
callus development, the initial woven bone is formed. This process is synthesized by 
mature osteoblasts. Osteogenic factors, such as BMP, are responsible for the 
differentiation of osteoprogenitors to mature osteoblasts. 
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3) Remodelling: (21+ days) The woven bone is replaced by cortical bone, and the 
medullary cavity is repaired [64]. Osteoclasts, which are the main cell type participating in 
the resorption of mineralized bone, are derived from the differentiation and fusion of 
myeloid/monocyte lineage precursors [76]. The period of the remodelling phase is 
dominated by transformational cycles of osteoblast and osteoclast behaviour. 
Fig. 3 Fracture healing. The biological stage of fracture healing is revealed in three main phases: 
inflammation, tissue repair and remodelling. The phases of inflammation are indicated in three 
events: protein adsorption, cell infiltration and cytokine release. The following phases of tissue 
repair and remodelling are indicated in two main events: MSC recruitment and differentiation, 
as well as turnover of osteoblasts and osteoclasts. 
2.3.3.  Control of fracture healing 
Normally, fracture healing is governed by the nature and extent of the wound, the stability of 
the implants (fracture fixation), and the regulation of biological processes, including the immune 
reactions and developmental processes associated with the bone [1]. In brief, successful 
fracture healing involves the following control elements: 1) immune reactions, 2) bone formation 
and 3) the implants. 
1) Immune reactions 
A fracture leads to the activation of the immune response. Activated platelets, macrophages 
and other inflammatory cells (granulocytes, lymphocytes and monocytes) infiltrate fractured 
sites, release cytokines and chemokines, and regulate the inflammation phase in fracture 
healing [77]. 
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Neutrophils and macrophages, acting as the main cells in the first natural immunological 
defence response to xenogenic materials (e.g., implants), have drawn the most attention 
because of their multiple functions in bone healing [19, 78]. It has been suggested that 
macrophages can recognize foreign implants via the Toll-like receptor (TLR) pathway, which 
stimulates an initial innate host response and could lead to material rejection [79]. In addition, 
macrophages, as secretory cells, modulate the function of other cell types and innate/adaptive 
immunity by releasing a range of cytokines, chemokines and growth factors. These factors 
include TNFα, IL1/6, macrophage colony stimulating factor (M-CSF), BMP, transforming growth 
factor beta 1 (TGFβ1), platelet-derived growth factor (PDGF), vascular endothelial growth factor 
(VEGF) and fibroblast growth factor (FGF) [75, 80-83]. Moreover, secretion could be regulated 
by some bioactive agents of implant materials (released ions, particles, etc.). 
Macrophage polarization also plays a vital role in fracture healing [84, 85]. Based on the 
microenvironment (space) and its evolution (time), macrophages can exhibit various 
phenotypes and functions, e.g., macrophage polarization plasticity. Thus, macrophages 
present various phenotypes [86]. From a historical and simplified perspective, the macrophage 
phenotype has been divided into 2 groups: M1 (classically activated macrophages) and M2 
(alternatively activated macrophages). Monocytes and activated macrophages could be 
polarized into an antimicrobial M1 type (proinflammatory macrophages) with the cytokine 
release of TNFα and interferon gamma (IFNγ). Additionally, a tissue regenerative M2 phenotype 
(anti-inflammatory macrophages) shows the secretion of IL10 and interleukin 1 receptor 
antagonist (IL1ra) [87, 88]. Normally, M1 induces chemokines such as IL8 and monocyte 
chemotactic protein 1 (MCP-1), and M2 induces chemokines such as osteopontin (OPN) [89]. 
The alternatively activated M2 has been shown to contain 3 subpopulations (e.g., M2a, M2b 
and M2c). Each of them has its own unique inducer, product and function [90]. 
These macrophages and their fused or polarized morphologic variants always remain at the 
material-tissue interface in vivo. This cell-cell fusion also contributes to the degradation of 
biomaterials via their phagocytosis and release of mediators [91, 92]. Over time, macrophages 
and neutrophils release lysosomes (digestive enzymes) and work with other phagocytic cells 
to clear degraded cells and debris (e.g., particles from implants) [93]. Adaptive immune cells, 
including T cells, B cells and natural killer (NK) cells, also play a role as indispensable 
modulators in bone healing [79]. Taken together, macrophages, cytokines and other released 
substances influence tissue healing and remodelling and can thus affect the mechanical 
properties and performance of biomaterials [79, 94, 95]. 
In recent years, it has become clear that MSC modulate the majority of immune cells [96-98], 
especially macrophage functions [84, 85, 99]. Fracture rehabilitation is significantly increased 
in vivo by skewing macrophage differentiation towards an anti-inflammatory phenotype (type 2 
macrophages: M2) [100]. Emerging results indicate that MSC (mediated by IL6 and lactate) can 
induce activated monocytes to polarize into an M2 phenotype [101-105]. Another study 
indicated that MSC could recruit M2 depending on NFκB and signal transducer and activator of 
transcription 3 pathway (STAT3) [106]. Accordingly, in vitro results have shown that MSC can 
regulate the immune response by influencing the activation and proliferation of B cells [107], 
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suppressing NK cell proliferation [108] and T cell/dendritic cell maturation [109], and inducing 
regulatory T cells (Treg) [110, 111]. In animal models, MSC also induce strong 
immunosuppressive effects or promote immunosuppression of effector T cells [112] and the T-
cell-mediated immune response [113, 114]. 
2) Bone formation 
The entire maturation process of osteoblasts, i.e., osteoblastogenesis, can be divided into 
proliferation, matrix maturation, mineralization, and apoptosis. Osteoprogenitor cells (MSC) 
start differentiating into preosteoblasts and begin to express adhesion and extracellular matrix 
(ECM; mostly synthesis). With the increase in the levels of alkaline phosphatase (ALP) activity, 
preosteoblasts further differentiate into mature osteoblasts. Then, the ECM components 
produced by osteoblasts mature and soon begin to mineralize in specialized sites. In the final 
stage, only a small proportion of cells survive as osteocytes (Fig. 4) [115]. 
Each phase of osteoblastogenesis can be followed by specific markers. High ALP activity and 
upregulated specific pro-osteogenic genes are indicators of osteogenic differentiation of MSC 
populations. These specific markers, e.g., COL1, type 1 collagen, are considered the main 
component of bone formation and can be found in most connective tissues, including cartilage, 
bone, tendon, and skin [116]. Osteocalcin (OC) is a regulator of osteogenesis that can be 
induced after MSC differentiation into osteoblast-like cells [117]. OPN, as a player in 
osteogenesis, also drives chemotaxis of immune cells (neutrophils, macrophages and mast 
cells) [118]. 
Fig. 4 Specific markers in different stages of osteogenic differentiation of MSC. Summarized by 
the former report [119]. 
After any bone tissue fracture or subsequent biomaterial implantation, the immune response is 
accompanied by bone tissue repair processes. Thus, immune cells, especially macrophages, 
play important roles in the cellular response of tissue repair [120, 121] by mediating cell 
recruitment, proliferation, and differentiation or by influencing different cells, e.g., fibroblasts 
[122], osteoblasts [100, 123], and endothelial cells [124]. 
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Specifically, macrophages can attract MSC to migrate quickly to damage sites by secreting 
factors, such as MCP-1, macrophage inflammatory protein (MIP-1a), and IL8 [125, 126]. In 
addition, the roles of immunoregulatory cytokines have been extensively studied when 
interacting with MSC, especially in bone tissue repair. W Zhao et al. (2012) confirmed that 
injected MSC interact with monocytes during treatment of liver fibrosis and macrophages and 
result in a high concentration of IL10 and decreased levels of TNFα and IL6 [127]. In coculture 
of macrophages with MSC, some studies found a decreased level of proinflammatory cytokines 
(TNFα and IFNγ) as well as an increased concentration of anti-inflammatory cytokines (IL4 and 
IL10) [128, 129]. Nevertheless, the involvement of TNFα in bone formation is still controversial, 
as the recruitment of MSC could be antagonized by this inflammatory factor [125, 126, 130]. 
However, TNFα was confirmed to elevate ALP activity and mineralization of MSC in a dose-
dependent manner by activating the NFκB pathway [131, 132]. Another proinflammatory 
cytokine, IL1β, could regulate bone repair by inhibiting osteoblast maturation and stimulating 
osteoclast activity [133-135]. In addition, TNFα, IL1β, and IFNγ were reported to suppress 
osteoblast differentiation and inhibit collagen synthesis [136-138]. 
Physiological bone formation is orchestrated by bone repair-related growth factors, including 
TGFβ1 [80] and BMP [139]. BMPs, a group of signalling molecules identified as members of 
the TGFβ superfamily, are multifunctional chemokines (Fig. 5) [140]. BMP2 and BMP6 are vital 
differentiation factors that promote cartilage ossification through cytokines as well as migration 
and differentiation of MSC, thereby inducing bone regeneration in the treatment of fractures 
[141-143]. 
BMP molecules regulate osteoblast differentiation through the classical BMP/Smad pathway. 
Smads are basically divided into three classes according to their function: BMP receptor-
regulated Smads (Smad 1/5/8), co-Smads (Smad 4), and inhibitory Smads (Smad 6/7) [144]. 
Typically, BMP initially activates BMP receptors of target cells, namely, a type 1 and type 2 BMP 
receptor (BMPR1 and BMPR2). Then, the activated BMP signals can be transferred via specific 
phosphorylating Smads (Smad 1/5/8). Ultimately, the Smads interact with Smad 4 to form a 
complex that will be subsequently translocated into the cell nucleus to modulate the key 
osteoblast transcription factors and related gene expression of osteogenic differentiation 
factors [145]. For instance, runt-related transcription factor 2 (RUNX2), which is also known as 
core-binding factor subunit alpha-1 (CBF-alpha-1), is regulated. RUNX2, as a master switch for 
inducing osteoblast differentiation [119], directly promotes the transcription of downstream 
target genes, including COL1, OC and OPN [146, 147]. 
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Fig. 5 BMP signalling pathway. The present graph is summarized from previous reports [141, 
148]. 
The regulatory factor IL6/OSM is another important player in immune cell-mediated 
osteogenesis [149, 150]. The IL6 family is a group of cytokines, including IL6, IL11, ciliary 
neurotrophic factor (CNTF), leukaemia inhibitory factor (LIF), OSM, cardiotrophin 1 (CT1), 
cardiotrophin-like cytokine (CLC), and IL27 [151]. These factors are grouped because they 
share a coreceptor (gp130). The gp130 protein is commonly expressed in most tissues and is 
responsible for signal transduction into cells by activating related cytoplasmic tyrosine kinases 
(such as JAK; Janus kinase) and leading to the phosphorylation of various transcription factors, 
particularly STAT3 [152-154]. 
IL6 is a proinflammatory cytokine that is normally expressed and/or stimulated in damaged 
tissue or stress [155, 156]. There are two types of IL6-mediated signals: classical IL6 signals 
and IL6 receptor (sIL6R) signals [157]. IL6 is essential for callus mineralization and maturation 
in a mouse model [158]. IL6 together with sIL6R stimulates osteogenic differentiation of MSC 
by activating STAT3 [159]. 
As shown in Fig. 6, IL6 binds and signals through its own unique receptor (IL6R) on the plasma 
membrane [154]. The complex of IL6/IL6R interacts with gp130 (coreceptor for the IL6 family) 
and results in an activated complex (IL6, IL6R and two molecules of gp130). Consequently, 
both signalling pathways contribute to the activation of JAK proteins, which are responsible for 
the phosphorylation of STAT recruitment, especially STAT3 [160].  
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Fig. 6 IL6 signalling pathway. The present graph is summarized in a previous report [160]. 
OSM is mainly released by immune cells, epithelial tissue cells, and stromal cells during the 
regulation of immune reactions [161-163]. OSM produced by monocytes/macrophages has 
been reported to promote the osteogenesis of human MSC [164] by activating STAT3 signalling 
in MSC (Fig. 7) [165]. OSM interacts with its receptors (OSMR/gp130). Then, the complex 
(OSM, OSMR, and gp130) results in JAK activation and the phosphorylation of STAT3 
recruitment (Fig. 7). 
Fig. 7 OSM signalling pathway. The present figure is produced based on previous work [166]. 
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Studies have examine the correlations of OSM/OSMR/gp130, STAT3 signals and ALP activity. 
For instance, the stimulation of pro-osteogenic activity by activated macrophages can be 
blocked with neutralizing antibodies to OSM, the OSM receptor subunits gp130 and OSMR, or 
the downstream transcription factor STAT3 [166]. Thus, neutralized OSM was related to the 
reduced ALP level in vitro [165]. Moreover, OSM knockout in mice led to decreased new bone 
formation [167]. 
3) The implants 
The immune reactions induced by the interaction that exists between the implants and 
biological systems contribute to both the success and failure of biomaterial implantation [168, 
169]. On the one hand, as a favourable host response, immune cells can secrete cytokines to 
stimulate bone tissue repair in addition to their inflammatory roles. On the other hand, 
macrophages act as key factors of excessive inflammation [170-172]. An excessive immune 
reaction may create continuous inflammation and the formation of granuloma and fibrous tissue 
around the implants. Thus, bone-forming cells cannot attach to the surface of implants to form 
new bone tissue, which will lead to implant loosening. 
Fig. 8 An excessive immune reaction resulting in encapsulation of an implant. Adapted from 
[173]. Reused with permission from Springer Nature Publishers, Ltd.: Nature Biotechnology. 
The excessive immune reactions of macrophages primarily respond to microenvironmental 
cues and the consequent events that occur due to biomaterial implantation. As shown in Fig. 8, 
macrophages react to implants by secreting molecules that attract fibroblasts. Fibroblasts 
subsequently generate excessive collagen. Their presence is associated with the formation of 
foreign body giant cells via fusion of monocyte-derived macrophages. Over time, a fibrous 
capsule is formed around the implants, completely separating the implants from the cellular 
components of the foreign body reaction (FBR) [95]. 
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In general, inflammation and formation of granulation tissue are common in wound healing and 
biomaterial implantation, while FBR is unique to implantation. The FBR to implants comprises 
foreign body giant cells and the components of granulation tissue (fibroblasts, macrophages, 
and capillaries) [174]. This inappropriate immune response of capsule formation, dominated by 
FBR, is suggested to be altered by biomaterials [79], which is determined by the match of 
implants and fractured tissue, as well as the interaction of implant shape and tethering forces 
[175]. 
Consequently, the host response starts immediately upon implantation of any material and lasts 
throughout tissue remodelling. The host's response to implants will be a key factor in 
determining the success or failure of any surgical or regenerative strategy. Strategies to 
influence or control macrophage polarization with positive effects on fracture (tissue) 
remodelling may lead to improved outcomes in biomaterials [176]. As a promising biomaterial, 
biodegradable Mg-based materials have attracted extensive interest. For instance, in vitro and 
in vivo studies demonstrated a direct role of Mg ions or their salts in suppressing inflammation 
[34, 35, 37]. In a mouse model, the anti-inflammatory effect of Mg oxide nanoparticles was 
reported [177]. Similarly, Mg alloys exhibited anti-inflammatory properties [13]. 
Implants can provide support for MSC adhesion and growth. Furthermore, the implants can 
affect MSC recruitment and osteogenic differentiation at fractured sites. Numerous reports in 
recent years have demonstrated that Mg ions can stimulate osteogenic differentiation of MSC 
and bone regeneration in vitro [39, 40]. Additionally, it has been shown that Mg-based alloys 
can promote bone formation in vivo [178, 179]. Magnesium–calcium phosphate cement (MCPC) 
has been reported to enhance the osteogenic capacity of MSC by decreasing TNFα and 
upregulating TGFβ1 [80]. 
Thus, osteoimmunomodulation (convergence of osteoimmunology and immunomodulation) 
could be an important feature of implants to stimulate tissue repair and eliminate fibrous 
encapsulation. When orthopaedic implants are designed, both biological and engineering 
methods can be applied to modify biomaterials and their degradable components. Various 
methods have been proposed to manufacture implants that release anti-inflammatory [180], 
pro-osteogenic [181, 182], and proangiogenic [183] drugs or mediators to reduce foreign body 
reactions. In some reports, the implant surface was modified to modulate the cellular response 
(e.g., inflammation and bone/cartilage formation) [184, 185]. 
2.3.4.  Models for investigating the interactions of MSC-immune cells 
The choice of in vitro models, such as indirect and direct contact cocultures, for studying the 
interactions of MSC-immune cells depends on the stage of the natural cell niche that needs to 
be mimicked or studied [186]. 
At the initial stages of immune reactions (Fig. 3), immune cells and MSC are in an indirect cell-
cell interaction stage (cell infiltration, recruitment, and cytokine exchange). Given these specific 
cellular and molecular interactions (Fig. 9), two different indirect in vitro coculture systems were 
established to explore various events: transwell coculture (TW) and conditioned media (CM) 
systems. In addition, MSC can regulate the immune response in a paracrine manner [187, 188]; 
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thus, a transwell coculture and conditioned media system should be applied. With higher 
complexity, a transwell coculture system involves two-way communication. By employing an 
indirect in vitro transwell coculture system, MSC and PBMC/macrophages grow separately 
while sharing the same microenvironment and soluble factors. Thus, the synergistic 
contribution of each cell type can be investigated. The conditioned media system is a one-way 
communication system, offering a simplified in vivo model while being more complex than a 
monoculture. Conditioned media has been used to investigate the single effect of MSC or 
PBMC/macrophage secretory cytokines on opposite cell types [189, 190]. 
In the subsequent fracture healing stage, immune cells and MSC will be in a direct cell-cell 
interaction. Thus, a direct-contact coculture system was also established to represent the 
physical interactions after MSC and PBMC/macrophages attached to the biomaterial surface 
(Fig. 3). A limitation of such direct cell-cell coculture is that it is not possible to distinguish the 
contribution of MSC or PBMC/macrophages in cytokine production. 
Fig. 9 Forms of chemical signalling and models for investigating the interactions of MSC 
(HUCPV)-immune cells (PBMC/macrophages).  
To investigate the osteoimmunomodulation of Mg-based materials, researchers used three 
factors in current in vitro models: bone-forming cells (MSC), immune cells, and Mg biomaterials. 
As a source of MSC, human umbilical cord perivascular cells (HUCPV) were selected as 
osteoprogenitor cells for these three in vitro systems. HUCPV exhibit a high proliferation rate 
and differentiation potential into an osteogenic phenotype, as well as low immunogenicity. For 
analysis of the initial stage of immune reactions, PBMC were applied as infiltrated immune cells 
in indirect coculture systems (conditioned media system and transwell coculture). PBMC, 
comprising monocytes (10%~20%), various lymphocytes (T cells, B cells, and NK cells; 
70%~90%), and dendritic cells (only 1%~2%), were isolated from human leukocyte-enriched 
blood samples. Subsequently, as one of the first key players during immune reactions, 
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macrophages were obtained or differentiated from CD14-positive monocytes isolated from 
PBMC. 
Pure Mg was chosen to avoid the complexity due to alloying elements. Gd, as a possible alloy 
element, can ameliorate material properties such as decreasing the degradation rate and 
improving mechanical properties [191]. Gd salts also show other interesting properties, such 
as modulation of inflammation [192, 193]. Furthermore, Mg-10Gd maintains its 
cytocompatibility and can even enhance osteoblast mineralization [194]. Therefore, pure Mg 
and Mg-10Gd were chosen to investigate the interactions between cells and biomaterials (third 
model). The advantages and disadvantages of each in vitro system are summarized in Table 4 
based on the previous results [195-197]: 
Table 4 Summary of different coculture systems. 
Names Advantages Disadvantages 
Conditioned 
media (CM) 
l Easy to handle, low cost and could be frozen 
for replicate experiments 
l Conditioned media system could be applied 
for more expanded range, i.e., cells from 
different species 
l Migration/wound healing assay 
l The variation of 
the medium 
composition, 
such as serum 
components and 
glucose 
Transwell 
coculture 
(TW) 
l The initial stage of biomaterial/immune 
response-mediated osteogenesis could be 
mimicked, allowing communications with no 
cell-cell contact 
l Changes in gene and protein expression could 
be investigated in a cell type-specific manner 
l Migration/wound healing assay 
l Variation due 
from difficult 
operation 
l High cost 
Direct 
coculture 
l Represents the in vivo cell-cell contact 
l Several signalling pathways could only be 
regulated in cell-cell contact 
l Limited 
discrimination of 
the influence from 
particular cell 
types  
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3. Motivation and objectives 
Osteoimmunomodulation is a vital and necessary process in fracture healing. Elucidation of 
this process can lead to better clinical therapy for chronic disease in relation to bone dynamic 
balance, in which immune cells are influenced by implants. For an expanded understanding of 
the roles of the material-modulated immune response in osteogenesis, two indirect in vitro 
systems (transwell coculture and conditioned media) and one direct coculture system were 
applied using PBMC/macrophages and bone-forming HUCPV.  
In the early stage (indirect coculture; within 7 days) of inflammation, PBMC were typically 
seeded on the top of the chamber and HUCPV in the lower compartment, avoiding cell-cell 
contact but allowing monocytes to differentiate into macrophages, while HUCPV could 
differentiate into osteoblast-like cells (transwell coculture system). Thus, cell proliferation, 
microscopic characteristics, gene expression, etc. could be monitored for each cell. Regarding 
the conditioned media system, HUCPV-conditioned media was utilized to examine the direct 
M2 differentiation potential, and PBMC-conditioned media was employed to investigate the 
induction of HUCPV towards a pro-calcification phenotype. Moreover, in the later stage (direct 
coculture; 7-14 days) of inflammation, a mixture of macrophages and HUCPV were coseeded 
on pure Mg and Mg-10Gd. Cell growth and cell subpopulations were followed. ALP activity and 
genes expression, known as indicators of osteogenic differentiation, were studied. Furthermore, 
the underlying specific signalling factors (IL6/OSM signals, BMP signals, etc.) and subsequent 
cascades creating a pro-osteogenic circumstance for bone regeneration were explored. The 
hypothesis of the present study is schematized in Fig. 10.  
In the early stage (indirect coculture; within 7 days) of inflammation: 
l Mg (+/-HUCPV) could induce anti-inflammatory properties, such as lower pro- or 
higher anti-inflammatory levels of released cytokines, as well as a favourable M2 profile; 
l Mg (+/-PBMC) could enhance the motility of HUCPV; 
l Mg (+/-PBMC) could stimulate the osteogenic potential of HUCPV. 
In the later stage (direct coculture; 7-14 days) of inflammation: 
l Mechanisms of materials (+/-macrophages) induced osteogenic differentiation: 
OSM/IL6; BMP6; TNFα/IL1β. 
 
Fig. 10 Hypothesis in the present study (indirect and direct coculture system). 
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4. Materials and methods 
4.1.  Material preparation and characterization 
High-purity Mg (99.93 %) and Mg-based alloys Mg-10Gd (9.44 % Gd, 90.51 % Mg) were 
supplied by Helmholtz-Zentrum Geesthacht, Germany. High-purity Mg (99.93 %) was prepared 
by permanent mould gravity casting. The produced ingots were processed by a heat T4 
treatment, extruded into rods of 10 mm in diameter, and finally Mg discs were cut (1.5 mm 
thickness). Each disc weight about 0.2 g. Mg-10Gd was manufactured in constant mould gravity 
casting, a T4 treatment was performed on the produced ingots, extruded into rods, and finally 
cut as discs with 10 mm in diameter and 1.5 mm in thickness. The composition of Mg and Mg-
10Gd were measured by X-ray fluorescence spectrometry according to weight percentage 
(Bruker AXS S4 Explorer, Bruker AXS GmbH, Germany), as shown in Table 5.  
Table 5 Compositions of Mg and Mg-10Gd. 
Biomaterials 
Composition wt.% 
Mg % Gd % Fe % Cu % Ni % Al % Be % 
Mg  99.93 - 0.0011 0.00024 <0.0002 0.018 0.000046 
Mg-10Gd  90.51 9.44 0.041 0.0020 <0.0038 - 0.000204 
4.2.  Sample sterilization, incubation, and characterization 
All samples were treated via sonication for 20 min in 100 % n-hexane, 100 % acetone, 100 % 
ethanol, as well as sterilization in 70 % ethanol (Merck, Darmstadt, Germany). Afterwards, the 
dry discs were pre-incubated for 24 hours in specific culture medium before seeding cells. 
To evaluate the corrosion behaviour of Mg and Mg-10Gd discs, the corrosion rates (CR; mm/y) 
were determined by the mass loss method and calculated using the following equation [198]: 
CR= 
∆m∙k
A∙t∙ρ 
The collected samples were washed in double distilled water. Samples were drying for 24 hours 
at 37 °C. Then weight the samples with corrosion layer (m0). The corrosion products were 
subsequently removed by chronic acid. Then dried the samples and weight them again (mt). 
The ∆𝑚 (g; m0- mt) represents the mass loss; k is constant (8.79 × 104); A represents the 
surface area (cm2); t means the culture time and ρ stands for the density of discs (g/cm3). 
Osmolality and pH of all the samples were measured with a cryoscopic osmometer (Gonotec 
030-D cryoscopic osmometer; Gonotec, Berlin, Germany) and a pH Meter (ArgusX Sentron pH 
meter; Sentron Europe BV, Roden, the Netherlands), respectively. Mg concentration (mM) in 
each cell culture supernatant was measured by atomic absorption spectroscopy (AAS) analysis 
(Agilent 240/280 Series AA; Agilent Technologies, Waldbronn, Germany). 
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4.3.  Cell isolation and culture 
HUCPV were isolated from perivascular site (Wharton's jelly) of umbilical cords. The isolation 
process was approved by Ethik-Kommission der Ärztekammer Hamburg (PV4058). The 
isolation can be divided in the following steps: 
1) Wash the umbilical cord with cold PBS to remove the blood. 
2) Dissect the umbilical cord to obtain the arteries. 
3) Ligate both ends of the arteries with sterilized surgical thread. 
4) Culture the ligated arteries in T175 flask (Fisher Scientific, Roskilde, Germany) with 
α minimum essential medium (α-MEM; Fisher Scientific GmbH, Schwerte, Germany) 
supplemented with 15 % (v/v) foetal bovine serum for human mesenchymal stem cell (SC-
FBS; Biological Industries, Beit-Haemek, Israel) and 1 % (v/v) Penicillin/Streptomycin (P/S; 
Life Sciences, Karlsruhe, Germany) under physiological condition (5 % CO2, 20 % O2, 95 % 
relative humidity, 37 °C). 
5) Cells proliferation were seen until no more than 70 % confluence to avoid the possible 
differentiation. Isolated HUCPV were expanded until they reached 5-8th passage. 
Human leukocytes-enriched blood samples were provided by University Hospital Hamburg-
Eppendorf (UKE; Hamburg, Germany). Then PBMC were isolated (Fig. 11) as follows: 
Fig. 11 PBMC isolation. PBMC: peripheral blood mononuclear cells; RBCs: red blood cells. 
1) Transfer 10 mL leukocyte-enrichment blood into a sterilized 50 mL tube.  
2) Fill up the tube with 40 mL ice-cold phosphate-buffered saline (PBS; Thermo-Fisher 
Scientific GmbH, Langenselbold, Germany) and mix thoroughly.  
3) Overlay carefully 25 mL PBS-diluted blood with 25 mL Ficoll Paque 400 (GE 
Healthcare, Chicago, Illinois, USA), avoiding the mixture of two layers.  
4) Centrifuge at 350 g for 30 min without brake at room temperature.  
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5) A visible white layer was accumulated at the interface between the PBS and Ficoll 
Paque 400. Then, collect the white ring (mononuclear hematopoietic precursors). 
6) Wash them with ice-cold PBS twice and the centrifuge at 300 g for 10 min (with brake).  
7) Seed 5×105 cells/well fresh-isolated PBMC immediately into inserts in indirect 
coculture, or use for the subsequent isolation CD 14 positive monocytes.  
The pooled human serum was used in the indirect coculture system instead of FBS to avoid 
variation of serum components, glucose and other possible activating factors in the cell culture 
medium. During the isolation of PBMC, the human serum was collected after step 4) via a 
centrifugation of 300 g for 10 min. The collected serum was filtered through a 0.45 µm sterile 
filter (Thermo-Fisher Scientific™, Langenselbold, Germany), pooled, and frozen at -20 °C for 
further use. Afterwards, α-MEM medium supplemented with 10 % human serum (v/v) and 1% 
P/S was used as culture medium in further indirect coculture system (transwell coculture and 
conditioned media system). 
To acquire macrophages for the direct coculture system, high purity monocytes were isolated 
and then differentiated into macrophages. CD 14 is a specific monocytes/macrophages antigen 
on the surface of myeloid lineage [199]. This positive selection of CD 14 positive monocytes 
will not activate the cells. The anti-human CD 14 M-pluriBead® (pluriSelect, Leipzig, Germany) 
and M-pluriBead® Maxi Reagent Kit (pluriSelect, Leipzig, Germany) was used to get high purity 
monocytes in three steps - samples preparation, incubation, washing and detachment as 
follows (Fig. 12): 
1) Prepare a single cell suspension with the fresh isolated PBMC in 500 µL dilution buffer 
and 500 µL washing buffer.  
2) Pre-filter the PBMC with S-pluriStrainer to remove aggregates.  
3) Add the samples and pluriBead suspension into a sterilized 15 mL tube and incubate 
them up to 30 min using a tube roller (Sunlab, Hamburg, Germany) at 10-15 rpm and 7.5° 
angel.  
4) Pour samples onto the pluristrainer, and wash the unbounded cells into a sterilized 
50 mL tube with at least 25 mL washing buffer. Meanwhile, the bead-bounded cells still 
remain on the strainer. At each wash step, the wash buffer was used in a circular way at 2 
steps of 1 mL wash buffer.  
5) Incubate the bead-bounded cells with detachment buffer for 10 min at room 
temperature. The bounded cells were detached from the pluriBeads.  
6) The (CD 14 positive) target cells were released with serum-free RPMI 1640 medium 
(Sigma-Aldrich, Munich, Germany) and flowed into fresh tubes.  
The isolated monocytes were characterized for their expression of FITC-conjugated CD 14 
(555397; BD PharmingenTM, Heidelberg, Germany) and analysed with a Bio-Rad S3e™ Cell 
Sorter (Bio-Rad Laboratories, Munich, Germany). The CD 14 positive of isolated monocytes 
was always above 95 %. 
To activate the differentiation of macrophages, the isolated monocytes were expanded as 3×106 
cells in 2 mL differentiation medium per well, in a 12-well plate, for 7 days under physiological 
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conditions. The differentiation medium was composed of RPMI 1640 medium, 2 mM L-
glutamine (Sigma-Aldrich, Munich, Germany), 10 mM HEPES (Lonza, Köln, Germany), 10 
μg/mL gentamycin (Sigma-Aldrich, Munich, Germany), 10 % (v/v) heat-inactivated FBS 
(Biochrom, Berlin, Germany) and 12.5 ng/mL macrophage colony-stimulating factor (M-CSF; 
Sigma-Aldrich, Munich, Germany). 
 
Fig. 12 The isolation of CD 14+ monocytes from PBMC. 
4.4.  Indirect in vitro coculture systems: transwell coculture and 
conditioned media system 
To study the influence of degradable Mg on the interaction between bone-forming cells and 
immune cells, an in vitro transwell coculture (Alvetex™ Strata, Glasgow, United Kingdom) and 
conditioned media system were applied.  
Fig. 13 Indirect in vitro coculture systems: transwell coculture of HUCPV and PBMC. 
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For transwell (Fig. 13), the wells in lower compartment were coated with 1 % (v/v) agarose 
(Sigma-Aldrich, Darmstadt, Germany) to avoid HUCPV adherence on the plate surface rather 
than Mg surface. HUCPV and PBMC, as a 1:2.5 ratio, were seeded on Mg surface in lower 
compartment and on inserts (5 µm pore size) in upper compartment of 12-wells plate, 
respectively (Fig. 13). As shown in Table 6, the groups of HUCPV, PBMC or their transwell 
coculture on Mg disc were nominated as H+Mg, P+Mg, or H+P+Mg. The medium was changed 
every 3 days. Samples were collected at day 1, 4 and 7 and stored at -80 °C until further 
analysis. Cell growth, gene expression, ALP activity and cytokine levels were investigated.  
 
Fig. 14 Indirect in vitro coculture systems: HUCPV/PBMC-conditioned media. 
For the conditioned media system (Fig. 14), to generate conditioned media, HUCPV or PBMC 
alone were cultured as 2×105 or 5×105 cells, respectively, per Mg disc or inserts. After 30 min 
adherence, HUCPV-seeded Mg discs or PBMC-seeded inserts were transferred into 12-wells 
plate with 2 mL culture medium for 24 hours. These conditioned media were termed as H+Mg 
CM or P+Mg CM (Table 6). After 24 hours, conditioned media (H+Mg CM and P+Mg CM) were 
harvested and centrifuged at 10000 g for 2 min. All the conditioned media were diluted with 
culture medium (1:1) and frozen at -80 °C until use. Cell growth and specific gene profiles, as 
well as ALP levels were also analysed. 
For both transwell coculture and conditioned media system, cell culture medium was set as 
blank control (termed as Blank). Mg disc incubated with cell culture medium but without any 
cell was used as no-cell controls (Mg or Mg CM). In transwell coculture without Mg discs, 
monoculture of HUCPV or PBMC and cocultured HUCPV and PBMC was applied as cell control 
(H, P or H+P). Without Mg disc, HUCPV or PBMC in conditioned media system were regarded 
as controls termed as H/P CM. 
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Table 6 Experimental conditions of the indirect in vitro coculture systems. 
Name No. Abbreviation Experimental conditions 
Transwell 
coculture system 
1 Blank Cell culture medium 
2 Mg Only Mg disc 
3 H HUCPV alone 
4 H+Mg HUCPV on Mg disc 
5 P PBMC alone 
6 P+Mg 
PBMC (upper compartment) with Mg disc 
(lower compartment) 
7 H+P Coculture of HUCPV and PBMC 
8 H+P+Mg 
Coculture of HUCPV on Mg disc (lower 
compartment) with PBMC (upper 
compartment) 
Conditioned 
media system 
1 Blank Cell culture medium 
2 Mg CM Only Mg disc 
3 H/P CM HUCPV/PBMC alone 
4 H/P+Mg CM HUCPV/PBMC with Mg disc 
4.5.  Direct in vitro coculture system 
Fig. 15 Direct in vitro coculture systems. 
As shown in Fig. 15 and Table 7, HUCPV alone, differentiated macrophages alone, and a 
mixture of HUCPV and macrophages were respectively seeded on the preincubated Mg and 
Mg-10Gd in 24-well plates. HUCPV alone (H+Mg/Mg-10Gd) and differentiated macrophages 
alone (M+Mg/Mg-10Gd) were seeded on discs as a cell number of 2.5×104 and 2.5×105 per 
well, respectively. In coculture, the 2.5×104 of HUCPV and 2.5×105 of macrophages were 
seeded together in each well of 24-well plates (H+M+Mg/Mg-10Gd). Cells culture medium 
without discs and cells were regarded as the blank control (Blank in Table 7). The groups only 
included material discs were termed as material controls (Mg/Mg-10Gd). HUCPV, macrophage, 
or their mixture directly cultured on wells (without discs), were used as cell controls (H, M or 
H+M). Differentiated macrophages were detached using buffer containing ice-cold PBS, 2 mM 
EDTA (Sigma-Aldrich, Munich, Germany) and 2 % FBS. The culture medium for direct coculture 
system was α-MEM supplemented with 15 % FBS and 1 % P/S. Medium was changed every 3 
days. 
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After 4, 7 and 14 days, the supernatant in each treatment were collected, centrifuged and frozen 
at -80 °C for ALP tests and cytokines analysis. Cells viability and proliferation as well as gene 
expression were investigated.  
Table 7 Direct in vitro coculture system. 
Name No. Abbreviation Experimental conditions 
Direct coculture 
1 Blank Cell culture medium 
2 H HUCPV on blank wells 
3 
H+Mg/Mg-
10Gd 
HUCPV seeded on materials surface 
4 M Macrophages on blank wells  
5 
M+Mg/Mg-
10Gd 
Macrophages seeded on materials surface 
6 H+M 
Coculturing of HUCPV and macrophages on 
blank wells 
7 
H+M+Mg/Mg-
10Gd 
Coculturing of HUCPV and macrophages on 
materials surface 
4.6.  Live/Dead staining and DNA contents 
Cellular membrane of alive cell is intact but incomplete in dead cells. The ubiquitous intracellular 
esterase activity is also another feature of alive cells. When staining at the same time, green 
fluorescent Calcein AM indicates intracellular esterase activity, and red fluorescent 
Ethidiumhomodimer-1 indicates loss of plasma membrane (Ethidiumhomodimer-1 could dye 
deoxyribonucleic acid only in cells with incomplete membrane). Therefore, the two highly 
fluorescent dyes of Live/Dead staining (LIVE/DEAD Viability/Cytotoxicity Kit for mammalian 
cells, Thermo–Fisher Scientific GmbH, Langenselbold, Germany) could differentially label alive 
(green) and dead cells (red).  
The staining steps are: 
1) Wash cells with Mg discs gently with serum-free α-MEM medium. 
2) Prepare the staining solution and avoid direct light in case of Calcein AM 
hydrolysation. The staining solution included 5 mL cell specific media without FBS, 1.6 mM 
Calcein AM, and 2.0 mM Ethidiumhomodimer-1.  
3) Incubate cells with staining solution for 20 min in dark at room temperature.  
4) Finally, replace the staining solution with serum-free α-MEM medium.  
5) Visualize the cells viability and morphology using an inverted microscope (Eclipse Ti, 
Nikon GmbH, Düsseldorf, Germany) immediately.  
To investigate proliferative cells on disc surface, the deoxyribonucleic acid (DNA) content was 
measured. In addition, DNA contents were used to normalize the variation induced by cell 
proliferation in other experiments. Chemicals and solutions involved in DNA measurement were 
prepared as shown in Table 8. 
The DNA isolation and quantification can be performed by following the steps below: 
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1) Digest the cells with 200 µL lysis buffer per well and incubated for 5 min at 37 °C.  
2) Collect the lysate and incubate for 1 hour at 98 °C and 1000 rpm using a thermomixer 
(Eppendorf thermomixer comfort, Hamburg, Germany).  
3) Reduce the lysate to 15 °C at 700 rpm using the thermomixer. In these steps, buffer 
without cells was also prepared as blank control for measurement.  
4) Add the same volume of neutralization buffer and centrifuge at 13000 rpm for 1 min.  
5) Dilute lysate samples as 1:5 (v/v) in DNA dilution buffer.  
6) Transfer 100 µL diluted sample to wells in a flat bottom 96-well-plate.  
7) Pipette 50 µL of DNA working solution and 50 µL of bisbenzimide (1:500 in working 
solution) into wells and incubate for 15 min in the dark.  
8) To obtain the standard curve, dilute gDNA into concentrations of 3, 1.5, 0.75, 0.375, 
0.188, 0.094, and 0.047 µg/mL, separately.  
9) Ultimately, measure fluorescence (excitation: 355 nm, emission: 460 nm) with a 
VICTOR3 multilabel microtiter plate reader (Perkin Elmer, Massachusetts, USA).  
10) Calculate the DNA content by plotting DNA content versus relative fluorescence in the 
standard curve. The linear equation is y = ax + b (y: relative fluorescence unit (RFU); a: 
the slope; x: DNA concentration; b: the intercept). 
Table 8 Chemicals of DNA assay.  
Buffer name Compositions Supplier 
Lysis buffer 
25.0 mM NaOH, 0.2 mM EDTA, pH 
6.0 
Sigma-Aldrich 
Chemie GmbH 
(Munich, Germany) 
Neutralization buffer 
40.0 mM Tris/HCl, Adjust pH to 5.5 
with HCl 
DNA dilution buffer 
2.5 M NaCl in 19.0 mM sodium 
citrate, pH 7.0 
DNA working buffer 
2.0 M NaCl in 15.0 mM sodium 
citrate, pH 7.0 
DNA standard Calf thymus DNA 
Bisbenzimide working 
solution 
2.0 µg/mL bisbenzimide in DNA 
working buffer 
4.7.  ALP activity 
The QuantiChromTM alkaline phosphatase assay (BioAssay Systems, Hayward, CA, USA) 
utilizes ρ-nitrophenyl phosphate (pNPP) that can be hydrolysed by ALP into a yellow coloured 
product- ρ-Nitrophenol. Therefore, the ALP activity can be quantified: 
1) Pipette the sample supernatant (50 µL) into each well of a clear bottom 96-well-plate.  
2) Prepare the total working solution for a whole 96-well assay by mixing 200 µL supplied 
Assay Buffer, 5 µL Mg acetate (5 mM) and 2 µL pNPP liquid substrate (10 mM).  
3) Pipette quickly the working solution (150 µL) into sample wells.  
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4) Use the same amount (200 µL) of distilled water and calibrator solution as controls.  
5) Read the optical density (OD) with 405 nm wavelength at the beginning (t0) and after 
4 min incubation (t4) using a microplate reader (Sunrise™ Tecan, Männedorf, 
Switzerland).  
6) Calculate ALP activity (IU/L=µmol/(L*min)) with following equation and normalize with 
the DNA content of HUCPV under according conditions: 
(ODsample t4 - ODsample t0)*Reaction volume*35.3
(ODcalibrator - ODwater)*Sample volume  
4.8.  Real time semi-quantitative polymerase chain reaction (RT-qPCR) 
4.8.1.  RNA purification 
The total cellular RNA was extracted by RNeasy Mini Kit (Qiagen, Hilden, Germany). 
1) Lysis the samples with RNeasy lysis buffer (buffer RLT) and harvest with QIA shredder. 
In which, buffer RLT contains a high level of guanidine isothiocyanate, which supports the 
binding of RNA to the silica membrane. 
2) Mix the lysate with 70 % (v/v) ethanol and place into a spin column so that the RNA 
can bind to the membrane of column.  
3) Wash them twice with buffer RW1 (contains a guanidine salt and ethanol, and is used 
for washing of membrane-bound RNA) and RPE (remove traces of salts, which are still on 
the column due to buffers RW1 used earlier in the procedure).  
4) After centrifugation, obtain the total RNA samples in 30 µL RNase-free water.  
5) Pipette a 1 μL sample onto a measurement pedestal of Nanodrop 2000c (Thermo-
Fisher Scientific GmbH, Langenselbold, Germany). The RNA content was measured by 
the absorbance at 260 nm. Also, the purity of RNA samples was ensured by the ratio of 
the absorbance at 260 to that at 280 nm (A260/280; the ratio for pure RNA is around 2.0).  
4.8.2.  Reverse transcription 
Complementary DNA (cDNA) was produced by reaction mixture using Omniscript or Sensiscript 
Reverse Transcriptase Kit depending on the amount of total template RNA (Qiagen, Hilden, 
Germany).  
1) Prepare the master mix. For each reaction, total volume of 8 µL master mix contained 
2 µL 10x buffer, 2 µL dNTP Mix (a solution containing sodium salts of dATP, dCTP, dGTP 
and dTTP), 2 µL Oligo-dT primer, 1 µL RNase inhibitor, and 1 µL Omniscript/Sensiscript 
Reverse Transcriptase. Oligo-dT primer is a better choice for cDNA synthesis, because of 
their specificity for mRNA, and also because it allows to study different targets from the 
same cDNA pool. 
2) Add template RNA and RNase-free water (total volume: 12 µL) into individual 8 µL 
master mix. The final volume for each tube is 20 µL.  
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3) Incubate the reaction mixture at 37 °C for 1 hour. 
4.8.3.  RT-qPCR 
Primers (Table 9) were designed via Primer 3 (version 4.0.0) or found in the RTPrimerDB 
databased. The primers were purchased from Eurofins MWG Operon (Ebersberg, Germany). 
The cDNA was quantified with specific primers, RT-qPCR, and SsoFastTM EvaGreen® 
Supermix (Bio-Rad Laboratories GmbH, Munich, Germany) using CFX96 TouchTM real-time 
PCR (software: version 3.1; Bio-Rad Laboratories GmbH, Munich, Germany). Beta 2 
microglobulin (B2M), glyceraldehyde3-phosphate dehydrogenase (GAPDH) and ribosomal 
protein L10 (RPL10) were selected as reference (endogenous) genes. No template control 
(NTC, no cDNA) was performed to exclude reaction contamination and primer dimerization. 
The relative fold of gene expression was calculated by 2 (-Delta CT) method (ΔΔCt).  
1) Dilute the cDNA product with RNase-free water as 1:40.  
2) Dilute the targeted primers into 20 μM with double distilled water (ddH2O).  
3) For each sample, mix the 1 µL diluted cDNA with 16.5 µL SsoFastTM EvaGreen® 
Supermix, 1.65 µL Forward/Reverse Primer, and 12.8 µL ddH2O.  
4) Pipette 10 µL sample into triplicate in 96-well plate and cover it with seal film (MSB 
101; Bio-Rad Laboratories, Munich, Germany).  
5) In a CFX96 TouchTM real-time PCR detection system, a thermal cycling was 
performed (Table 10).  
Table 9 Primers sequences. 
Full name Abbreviation Sequences 
Alkaline 
phosphatase 
ALP 
Forward: 5’-CACCCACGTCGATTGCATCT-3’ 
Reverse: 5’-TAGCCACGTTGGTGTTGAGC-3’ 
Collagen type I 
alpha 1 
COL1A1 
Forward: 5’-AAGACATCCCACCAATCACC-3’ 
Reverse: 5’-GCAGTTCTTGGTCTCGTCAC-3’ 
Osteocalcin OC 
Forward: 5’-ATGAGAGCCCTCACACTCCT-3’ 
Reverse: 5’-TGGACACAAAGGCTGCAC-3’ 
Osteopontin OPN 
Forward: 5’-CTCCATTGACTCGAACGACTC-3’ 
Reverse: 5’-CAGGTCTGCGAAACTTCTTAGAT-3’ 
B2 microglobulin B2M 
Forward: 5’-TGCTGTCTCCATGTTTGATGTATCT-3’ 
Reverse: 5’-TCTCTGCTCCCCACCTCTAAGT-3’ 
Glyceraldehyde3-
phosphate 
dehydrogenase 
GAPDH 
Forwards: 5’-GTCGGAGTCAACGGATTTG-3’ 
Reverse: 5’-TGGGTGGAATCATATTGGAA-3’ 
Ribosomal 
protein L10 
RPL10 
Forwards: 5’-AGTGGATGAGTTTCCGCTTT-3’ 
Reverse: 5’-ATATGGAAGCCATCTTTGCC-3’ 
Bone 
morphogenetic 
protein 6 
BMP6 
Forward: 5’-AGCGACACCACAAAGAGTTCA-3’ 
Reverse: 5’-GCTGATGCTCCTGTAAGACTTGA-3’ 
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Table 9 (Continued) 
 
Table 10 Protocol of the thermal cycling. 
Step  Duration Temperature  Cycle  
Initial duration  3 min 95 °C  1  
Denaturation  20 sec 95 °C  40 
Primer-annealing 20 sec 60 °C 40 
Elongation  30 sec 75 °C  40 
Denaturation  30 sec 95 °C  1  
Melting curve  5 sec 65-95 °C  0.5 °C/step  
4.9.  Flow cytometry analysis 
4.9.1.  M2 macrophages polarisation in indirect coculture (transwell coculture and 
conditioned media) system 
To study the effects of Mg and/or HUCPV on the monocytes/macrophages variation, the ratios 
of M2 in PBMC (cluster of differentiation (CD) 68+) were measured with flow cytometry. 
Intracellular antigen CD 68 [200] (FITC, 130-096-964; Miltenyi Biotec GmbH, Bergisch 
Gladbach, Germany), a transmembrane glycoprotein, heavily glycosylated in its extracellular 
domain, with a molecular weight of 110 kD, is a pan marker for monocyte lineage - 
macrophages, so it was used to identify the activated macrophages from PBMC. Meanwhile, 
antibody anti-human CD 163-PE (560933; BD Biosciences, Heidelberg, Germany), a 
scavenger receptor for haptoglobin–haemoglobin complexes, was selected as specific marker 
Full name Abbreviation Sequences 
Bone 
morphogenetic 
protein receptor 
type 1a 
BMPR1A 
Forward: 5’-ACTGCCCCCTGTTGTCATAG-3’ 
Reverse: 5’-AATGAGCAAAACCAGCCATC-3’ 
Bone 
morphogenetic 
protein receptor 
type 2 
BMPR2 
Forward: 5’-CTGCCCTGTTACTGCCATTATT-3’ 
Reverse: 5’-GGCAGCAGTATACAGATAGGTG-3’ 
Mothers against 
decapentaplegic 
homolog 1 
Smad1 
Forward: 5’-GTATGAGCTTTGTTAAGGGC-3’ 
Reverse: 5’-TAAGAACTTTATCCAGCCACTGG-3’ 
Mothers against 
decapentaplegic 
homolog 4 
Smad4 
Forward: 5’-CTCCAGCTATCAGTCTGTCAG-3’ 
Reverse: 5’-CCCGGTGTAAGTGAATTTCAAT-3’ 
Mothers against 
decapentaplegic 
homolog 5 
Smad5 
Forward: 5’-TCATCATGGCTTTCATCCCACC-3’ 
Reverse: 5’-GCTCCCCAACCCTTGACAAA-3’ 
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for M2 population [201]. Thus the proportion of M2-macrophages in PBMC (M2/CD 68+) was 
represented by the percentage of double positive (CD 68 and CD 163) in all single positive (CD 
68) events: (CD 68+ CD 163+)/CD 68+ cells (%). 
Single staining of CD 68-FITC and CD 163-PE were used for the further results compensation 
[202]. Propidium iodide (PI) solution (ReadiDrop™; Bio-Rad Laboratories, Munich, Germany) 
was used to exclude dead cells from each analysis. Isotype controls were corresponding mouse 
IgG2b (130099119; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) and IgG1 (559320; 
Thermo–Fisher Scientific GmbH, Langenselbold, Germany). Samples without antibodies 
staining were applied as blank controls.  
The detailed procedures are as follows: 
1) Wash the cell pellet two times with ice-cold PBS and centrifuge at 1000 rpm for 5 min.  
2) Resuspend the cells as 1×106 cells per tube in 1 mL ice-cold PBS containing 1 % 
bovine serum albumin (BSA, albumin fraction≥98 % (v/v); Carl Roth, Karlsruhe, Germany).  
3) Dilute Anti-human CD 163-PE as a ratio of 1:10 in ice-cold PBS.  
4) Incubate cells with 20 μL CD 163 solution, on ice in the dark with gentle shaking, for 
1 hour.  
5) Wash cells twice with ice-cold PBS. 
6) Fix them with 3.7 % (v/v) formaldehyde (Sigma-Aldrich, Darmstadt, Germany) and 
permeabilize with 0.7 % (v/v) Tween 20 (Sigma-Aldrich, Darmstadt, Germany).  
7) Wash cells with ice-cold PBS twice. 
8) Dilute Anti-human CD 68-FITC as 1:10 in PBS.  
9) Stain the cells with intracellular anti-human CD 68-FITC at room temperature in the 
dark with gentle shaking for 30 min.  
10) Finally, wash samples again and resuspend them in PBS with 1 % BSA.  
11) With help of flow cytometer (S3e; Bio-Rad Laboratories, Munich, Germany), 
investigate the immunophenotyping of CD 68 and/or CD 163. The corresponding 
fluorescence intensity of different conditions and their propidium iodide (PI) staining were 
detected via the collection of 5000 to 10000 events per assay. 
4.9.2.  Subpopulations of HUCPV/macrophages in cocultures in direct coculture 
system 
To measure the subpopulation of HUCPV and macrophages in cocultures upon the stimulation 
of Mg biomaterials (Mg and Mg-10Gd), the collected cells were investigated with flow cytometry. 
HUCPV were stained with specific surface antigen-CD 90 [203] (A15761; Thermo-Fisher 
Scientific GmbH, Langenselbold, Germany). CD 90 (Thy-1) is a small membrane 
glycophosphatidylinositol (GPI) anchored protein.  
Propidium iodide (PI) drop solution (Bio-Rad Laboratories, Munich, Germany) was used to 
exclude dead cells from each analysis. Isotype controls were corresponding mouse IgG1 
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(559320; Thermo-Fisher Scientific GmbH, Langenselbold, Germany). Samples without 
antibodies staining were applied as blank controls.  
The procedure is as follows:  
1) Wash the collected cell pellet two times with ice-cold PBS and centrifuge at 1000 rpm 
for 5 min.  
2) Resuspend the cells as 1×106 cells per tube in 1 mL ice-cold PBS containing 1 % 
bovine serum albumin.  
3) Dilute Anti-human CD 90-FITC as a ratio of 1:10 in ice-cold PBS.  
4) Incubate cells with 20 μL CD 90 solution, on ice in the dark with gentle shaking, for 1 
hour.  
5) Wash samples and resuspend them in PBS with 1 % BSA.  
6) With help of flow cytometer, investigate the immunophenotyping of CD 90. The 
corresponding fluorescence intensity of different conditions and their propidium iodide (PI) 
staining were detected via the collection of 5000 to 10000 events per assay. 
4.10. Multiplex immunoassay 
Normal enzyme-linked immunosorbent (ELISA) assays could detect only individual molecules 
in each well or each plate. The vital pros of ELISA are easy to use, high flexibility and low cost. 
Different from this, multiplex immunoassay is a beads-based multiplex immunoassay. Firstly, 
each identifiable bead with a distinct colour bead or spectral address, that allows for the 
simultaneous detection of multiple molecules in a single well (only with 12.5 μL serum or 50 μL 
cell culture supernatant) or plate. Besides, in this technology, one antibody to a specific analyte 
is attached to a set of beads of the same colour, while another antibody to the analyte is 
attached to a fluorescent reporter dye. The detector comprising two lasers that excite the beads 
and fluorescent reporter. The fluorescence data could be detect efficiently by identifying the 
specific target and measuring the number of specific molecules connect the coupled beads. 
The instructive scheme of multiplex immunoassay is introduced in the Fig. 16.  
To investigate the secretory production from HUCPV and/or PBMC under the stimulation of Mg 
in transwell coculture system, a panel of selected human inflammatory factors (Bio-Plex ProTM 
Human Cytokine 27-plex Assay; Bio-Rad Laboratories, Munich, Germany) was applied in our 
experiments. The principle of this beads-based assay is similar to those of sandwich enzyme-
linked immunosorbent (ELISA) assays but allows simultaneous detection of multiple analytes 
in a single well or reaction. The beads, with a distinct colour or spectral address, are coupled 
covalently to capture (i.e., specific) antibodies. These coupled beads directly react to the 
multiple targeted or desired molecules in samples. After several washing steps to remove the 
unbound protein, a biotinylated detection antibody is pipetted into each well to form a sandwich 
complex. The final detection complex is consisted of this sandwich complex and streptavidin-
phycoerythrin (PE; PE acts as a fluorescent indicator) conjugate. The cytokines measured in 
this assay are presented in Table 11.  
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Fig. 16 The scheme of multiplex immunoassay. 
The procedure is as follows: 
1) Soak the 96-well plate by ddH2O, in which 50 µL beads was added into each well.  
2) After 30 min incubation under room temperature, wash the plate twice with 100 µL 
supplied washing buffer using an automatic plate washer (Bio-Rad Laboratories, Munich, 
Germany).  
3) Add 50 µL standards, blanks and samples into wells. 
4) Incubate at room temperature with shaking at 850 rpm for 30 min (Eppendorf 
thermomixer comfort, Hamburg, Germany).  
5) After washing three times, pipette 25 µL 1× detection antibody into each well. 
6) Incubate with shaking at 850 rpm for 30 min at room temperature.  
7) Wash the bounded samples three times.  
8) Pipette 50 µL 1× streptavidin-phycoerythrin (PE) into each well. 
9) Incubated with shaking at 850 rpm for 10 min at room temperature.  
10) Wash the plate three times.  
11) Finally, resuspend the mixture in each well with 125 µL assay buffer and shake at 850 
rpm for 30 sec.  
12) Read the fluorescence and analyse using Bio-PlexTM 200 system supplemented with 
Bio-Plex ManagerTM (Bio-Rad Laboratories, Munich, Germany).  
The plate was covered with a dark stealing tape during each shaking step. All the incubation 
procedures were performed in dark and direct light was avoided.  
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Table 11 Cytokines and functions investigated by multiplex immunoassay. 
Function  Full name Abbreviation 
Pro-inflammatory 
Interleukin 1 beta IL1β 
Interleukin 2 IL2 
Tumour necrosis factor alpha TNFα 
Interferon gamma IFNγ 
Anti-inflammatory 
Interleukin 10 IL10 
Interleukin 4 IL4 
Interleukin 5 IL5 
Interleukin 13 IL13 
Interleukin 1 receptor antagonist IL1RA 
Granulocyte-colony stimulating factor G-CSF 
Migration/Wound 
healing 
Interleukin-8 IL8 
Granulocyte-macrophage colony-stimulating 
factor 
GM-CSF 
Monocyte chemoattractant protein 1 MCP-1 
Macrophage inflammatory proteins 1 alpha MIP-1α 
Macrophage inflammatory proteins 1 beta MIP-1β 
Angiogenesis 
Basic fibroblast growth factor bFGF 
Vascular endothelial growth factor VEGF 
Others  
Interleukin 6 IL6 
Interleukin 7 IL7 
Interleukin 9 IL9 
Interleukin 12 IL12 
Interleukin 15 IL15 
Interleukin 17 IL17 
Interferon gamma-induced protein 10 IP10 
Platelet-derived growth factor-BB PDGF-BB 
Regulated upon activation, normal T cell 
expressed and presumably secreted 
RANTES  
A chemoattractant cytokine (chemokine) 
selective for eosinophils 
Eotaxin 
4.11. ELISA 
To investigate specific cytokines, the protein production of TNFα, IL1β, OSM and IL6 were 
detected with ELISA (R&D Systems, Abingdon, UK) as following procedures (Fig. 17). Capture 
antibody was lyophilized with epitopes and response to the specific antigen of targets. Detection 
antibody, designed as biotinylated antibody, connected with the capture antibody and 
streptavidin-horseradish peroxidase (HRP). Streptavidin-HRP has a high affinity for biotin and 
is extensively used in molecular biology. Biotinylated secondary antibodies were used for 
amplifying targeted signals. As multiple biotin molecules can conjugate to one secondary 
antibody, the biotinylated secondary antibodies allow detection of proteins expressed at low 
levels. The materials used for this procedure are listed in Table 12. 
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Fig. 17 Procedures of ELISA. 
The procedure is as follows: 
1) Dilute capture antibody in PBS to the working concentration.  
2) Coat the 96-well plates with 50 μL capture antibody, cover with sealers, and incubate 
at room temperature overnight.  
3) Rinse the plates twice with wash buffer using automatic plate washer. 
4) Pipette 150 μL 1× reagent buffer into each well and incubate at room temperature for 
1 hour to block the plates. 
5) Rinse the plates twice with wash buffer using the auto washer. 
6) Add 50 μL of standards, unknown samples and blank controls into according wells 
and incubate for 1 hour at room temperature.  
7) Rinse the plates twice with wash buffer using the auto washer. 
8) Add detection antibody (diluted with 1× reagent buffer) as 50 μL per well and incubate 
for 1 hour at room temperature.  
9) Rinse the plates twice with wash buffer using the auto washer. 
10) Dilute the Streptavidin-HRP with reagent buffer into working solution, add as 50 μL 
per wells and incubate in the dark for 20 min.  
11) Rinse the plates twice with wash buffer using the auto washer. 
12) Add 50 μL of substrate solution to each well and incubate in the dark for another 20 
min.  
13) Terminate the reaction with 25 μL of stop solution in each well.  
14) Gently tap the plate to mix solution thoroughly.  
15) Detect the optical density (OD) of each well immediately using a Sunrise™ microplate 
reader at 450 nm wavelength (540 nm as reference). 
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Table 12 Materials and kits for ELISA. 
Content Name Supplier 
Human TNFα DuoSet® ELISA TNFα kit 
R&D Systems, 
Abingdon, UK  
Human IL1β DuoSet® ELISA IL1β kit 
Human OSM DuoSet® ELISA OSM kit 
Human IL6 DuoSet® ELISA IL6 kit 
Stabilised hydrogen peroxide (H2O2), 
stabilised with tetramethylbenzidine 
(TMB) 
Substrate 
solution 
Plate sealer Sealers 
Comprehensive collection of reagents 
and plates 
Reagent buffer 
2 N sulfuric acid (H2SO4) Stop solution 
Gibco™ phosphate-buffered saline buffer PBS 
Thermo - Fisher 
Scientific GmbH, 
Langenselbold, 
Germany 
Nalgene syringe filter, sterile, SFCA 
membrane, 0.2 μm 
0.2 μm filter 
0.05 % (v/v) Tween® 20 in PBS, pH 7.3 
adjusted with 20 % (v/v) hydrochloric acid 
(HCl) 
Wash buffer 
ELISA plate, high binding, flat base ELISA plate 
Sarstedt, Nümbrecht, 
Germany 
Polyethylene glycol sorbitan monolaurate Tween® 20 Sigma-Aldrich, Germany 
Bio-Plex Pro™ wash station Autowasher 
Bio-Rad Laboratories, 
Munich, Germany 
Sunrise™ microplate reader Plate reader 
Tecan, Männedorf, 
Switzerland 
4.12. Wound healing assay 
To investigate the motility of HUCPV stimulated by Mg-discs or - conditioned media, a scratch 
assay was employed (Fig. 18). Normally, in vitro “wound” was created by a straight line scratch 
across the HUCPV monoculture. Measurements are usually limited for 24 hours to study the 
migration, as well as reduce the contribution of cell proliferation on gap filling [204]. 
Fig. 18 The wound healing assay of HUCPV. 
The procedure is as follows: 
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1) Seed HUCPV as 1×105 cells per well of the 12-well plates in α-MEM culture medium 
until the cell reach 80 % confluence.  
2) Replace the medium with low serum (1 % FBS) to starve cells for overnight under 
physiological conditions in an incubator.  
3) Treat the cell with 0.01 mg/mL mitomycin C for 2 hours [205] (Sigma-Aldrich, Munich, 
Germany) in each well.  
The starvation and mitomycin C solution were used to synchronize cell cycle and avoid 
unnecessary cellular proliferation [204]. In addition, mitomycin C inhibits DNA synthesis [204], 
but it has no effect on RNA, protein synthesis, cytokine levels and gene profiles etc. [206].  
4) Use a standard 1 mL pipette to produce the scratch (no cell area) in the middle of 
each well.  
5) After scratching, take photographs immediately (T0) with an inverted microscope 
under bright light (Eclipse Ti, Nikon GmbH, Düsseldorf, Germany).  
6) Afterwards, incubate the scratches with control medium (α-MEM with 10 % plasma), 
corresponding Mg disc from transwell coculture or conditioned media treatments for 
another 24 hours.  
7) Visualize the scratches in the same area of each well (T24).  
8) Analyse the relative cell migration distance automatically with the difference between 
T0 and T24 via NIS-Elements Imaging Software (Nikon, Minato, Japan).  
4.13. Neutralization experiment 
Mg materials have been proved to stimulate the secretion of soluble factors of macrophage. 
Thus, the osteogenic differentiation of HUCPV could response to such Mg-modulated 
macrophage and soluble factors.  
Human anti-OSM is an inhibitor for OSM protein. OSM receptor is composed of gp130/OSMR 
(Fig. 7). IL6 could connect to receptor complex IL6R/gp130 and sIL6R/gp130 (Fig. 6). Therefore, 
anti-OSM was chosen for blocking OSM antigen while an anti gp130 was selected as co-
blocking antibody for both OSM and IL6. A neutralization experiment was performed to 
investigate effects of OSM and gp130 neutralization.  
HUCPV and macrophages were cultured as mixture in culture medium with 0.2 μg/mL human 
anti-OSM (MAB295; R&D Systems, Abingdon, UK), 0.2 μg/mL human anti-gp130 (MAB228; 
R&D Systems, Abingdon, UK) or both antibodies. According monoclonal mouse IgG1 (555748; 
BD BioScience, Germany) and IgG2a (555573; BD BioScience, Germany) were applied as 
isotype controls. Cocultures without blocking antibodies were selected as controls.  
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4.14. Statistical analysis 
Overall, for all in vitro systems (transwell coculture, conditioned media and direct contact 
system), data was acquired from at least biological duplicate of three independent experiments 
came from at least two donors of HUCPV, PBMC or macrophages, resulting in samples size 
n≥12. The data are presented as mean ± standard deviation (SD). The statistical significance 
between two conditions was analysed by t-test. The statistical significance between multiple 
comparisons was analysed by one-way ANOVA or one-way ANOVA on ranks using the 
SigmaPlot 13.0 (Systat Software Inc, USA). The following post hoc multiple comparisons were 
based on Turkey when equal variance was assumed or Dunn’s when equal variance was not 
assumed (α=0.05, *P≤0.05, **P≤0.01, and ***P≤0.001). For RT-qPCR, the regulation threshold 
(expression fold-change) and p-values (a measure of the evidence against the null hypothesis 
according to the statistical test) were set to 1.5 and 0.05, respectively. To detect differential 
expression, a t-test (P≤0.05) was employed and directly calculated using CFX Manager 
Software (Bio Rad, Munich, Germany; version 3.0).
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5. Results  
5.1.  Interactions between PBMC and HUCPV in an indirect coculture 
(transwell coculture and conditioned media) system  
5.1.1.  Mg content, pH, and osmolality characterisation 
The experimental conditions, Mg concentration and the pH and osmolality of the supernatants 
at each time point were analysed. Because of the degradation of Mg over time, the Mg 
concentration, pH and osmolality characterisation under different conditions of transwell 
coculture were determined at days 1, 4, and 7 (Table 13). The conditioned media were prepared 
via dilution of the collected conditioned media. The specimen characterisations of the diluted 
conditioned media are shown in Table 14. 
Table 13 The Mg concentration under different conditions in the transwell coculture system. The 
blank group at day 0 was also characterised (Mg concentration: 0.71 mM; pH: 7.60; osmolality: 
0.31 Osmol/kg). The transwell coculture data were obtained from biological duplicates of three 
independent experiments, resulting in a sample size of n=6. H: HUCPV; P: PBMC.
Timepoints Conditions 
Mg 
(mM) 
pH 
Osmolality 
(Osmol/kg) 
Day 1 
Mg 7.66±0.074 8.27±0.004 0.33±0.013 
H 0.68±0.007 8.10±0.012 0.31±0.007 
H+Mg 5.74±0.001 8.15±0.041 0.25±0.006 
P 0.54±0.002 8.05±0.009 0.31±0.007 
P+Mg 4.71±0.011 8.23±0.022 0.32±0.009 
H+P 0.64±0.001 8.27±0.004 0.31±0.003 
H+P+Mg 6.87±0.043 8.27±0.051 0.26±0.008 
Day 4 
Mg 11.75±0.079 8.20±0.013 0.36±0.023 
H 0.63±0.005 8.05±0.029 0.33±0.013 
H+Mg 18.03±0.070 8.27±0.030 0.28±0.015 
P 0.64±0.004 8.10±0.023 0.32±0.009 
P+Mg 15.62±0.064 8.31±0.066 0.35±0.029 
H+P 0.70±0.003 8.20±0.013 0.32±0.005 
H+P+Mg 17.91±0.083 8.32±0.039 0.27±0.015 
Day 7 
Mg 8.36±0.044 8.30±0.054 0.34±0.003 
H 0.60±0.002 8.10±0.013 0.32±0.017 
H+Mg 13.81±0.206 8.24±0.009 0.33±0.012 
P 0.78±0.004 8.14±0.015 0.33±0.008 
P+Mg 8.19±0.057 8.23±0.036 0.34±0.009 
H+P 0.69±0.003 8.25±0.132 0.34±0.017 
H+P+Mg 14.86±0.107 8.26±0.058 0.32±0.010 
In the transwell coculture system, the Mg concentration under conditions without an Mg disc 
showed a similar range (0.54 to 0.78 mM) compared to the blank (0.71 mM). With Mg disc 
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treatment in the transwell coculture system, the Mg concentration in the cell-seeded conditions 
(i.e., H+Mg, P+Mg and H+P+Mg) ranged from 4.71 to 6.87, 15.62 to 18.03, and 8.19 to 14.86 
mM, respectively, at various time points.  
As shown in Table 13, according to the pH values in all experimental conditions of the transwell 
coculture system, Mg and/or cells were exposed to a pH range from 8.05 to 8.32. The pH value 
under each condition was clearly higher compared to the culture medium (blank group at day 
0; pH: 7.60).  
Consistently, under different conditions in the transwell coculture system, the osmolality of the 
supernatants ranged from 0.25 to 0.36 Osmol/kg (osmolality in the blank group: 0.31 Osmol/kg). 
Table 14 The Mg concentration, pH and osmolality under different conditions in the conditioned 
media system. The blank group at day 0 was also characterised (Mg concentration: 0.71 mM; 
pH: 7.60; osmolality: 0.31 Osmol/kg). The data in transwell coculture were obtained from 
biological triplet tests, resulting in a sample size of n=3. H: HUCPV; P: PBMC.
Conditions Mg (mM) pH 
Osmolality 
(Osmol/kg) 
Mg-CM 3.82±0.226 8.13±0.004 0.33±0.011 
H-CM 0.69±0.035 8.13±0.012 0.27±0.017 
P-CM 0.63±0.035 8.10±0.010 0.30±0.007 
(H+Mg)-CM 3.51±0.250 8.47±0.040 0.30±0.009 
(P+Mg)-CM 3.12±0.025 8.15±0.020 0.31±0.006 
All the conditioned media were diluted with culture medium (1:1; v/v), and thus, under conditions 
with Mg in this system, the Mg concentration was kept at approximately 3-4 mM. The Mg 
concentration under conditions without an Mg disc had a similar range (0.63 to 0.69 mM) 
compared to the blank (0.71 mM) in conditioned media system. Without Mg discs, the Mg 
concentration was 0.63 and 0.69 Mm.  
In the conditioned media system, the pH value normally ranged from 8.10 to 8.50. The pH value 
in the conditioned media system was also elevated compared to the culture medium with a pH 
value of 7.60. 
The osmolality under each condition was approximately 0.30 Osmol/kg, similar to the culture 
medium (osmolality: 0.31 Osmol/kg). 
5.1.2.  Cell viability and proliferation 
To evaluate the effects of the Mg disc on cell viability and proliferation, live/dead staining and 
the DNA content of HUCPV and PBMC were investigated in the transwell coculture (Fig. 19) 
and conditioned media (Fig. 20) systems. After staining, the bright green cells represent live 
cells, whereas red fluorescent ones indicate dead cells with incomplete membranes. The DNA 
content directly correlates with cell number and could reflect the cell content in monoculture 
and cocultures upon stimulation by the Mg discs. 
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Fig. 19 Cell viability and proliferation of HUCPV in the transwell coculture system. (a) Live/dead 
staining of HUCPV. The green and red spots represent live and dead cells, respectively. (b) 
The DNA content of HUCPV. The scale bar represents 500 μm. The bars represent the mean 
± SD (n≥12). The asterisks indicate significant differences between the two conditions (ANOVA; 
α=0.05, *P≤0.05). H: HUCPV; P: PBMC. 
In the transwell coculture system, adherent HUCPV could be found under all experimental 
conditions up to 7 days of culture (Fig. 19a, green). For HUCPV cell growth, on day 1, the Mg 
disc increased the HUCPV cell number (Fig. 19a) and DNA content (Fig. 19b) compared to the 
HUCPV cell monoculture. During the subsequent culture period, the PBMC stimulated HUCPV 
cell growth under H+Mg vs. H+P+Mg (day 4) and H+Mg vs. H+P conditions (day 7), rather than 
the Mg discs. However, decreased DNA content was observed at day 7 compared to the control 
groups. The HUCPV cell monocultures in the control wells as well as the HUCPV-PBMC 
cocultures with and without Mg discs showed no obvious changes in the number of dead cells 
(red) and alive cells (green). Again, similar observations were observed for the corresponding 
DNA contents. 
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Fig. 20 Cell viability and proliferation of PBMC in the transwell coculture system. (a) Live/dead 
staining of PBMC. The green and red spots represent live and dead cells, respectively. (b) The 
DNA content of PBMC. The scale bar represents 200 μm. The bars represent the mean ± SD 
(n≥12). The asterisks indicate significant differences between the two conditions (ANOVA; 
α=0.05, *P≤0.05). H: HUCPV; P: PBMC. 
PBMC growth in the transwell coculture system is summarised in Fig. 20. Under the presence 
of the Mg disc, PBMC proliferation (Fig. 20a, green) was observed, but the number of dead 
PBMC did not significantly increase. As suggested by the DNA results, the number of PBMC 
was elevated on days 4 and 7 in the presence of Mg, H or both (Fig. 20b). PBMC exposed to 
Mg proliferated much faster than those cultured with HUCPV at days 1 and 4.  
In the conditioned media system, the HUCPV grew well on plastic during the entire culture 
period. Almost no obvious dead cells (red colour) were observed (Fig. 21a). For HUCPV cell 
differentiation, conditioned media from treatments with Mg, PBMC, or both did not markedly 
affect the DNA content at days 1, 4 and 7 (Fig. 21b).  
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Fig. 21 Cell viability and proliferation of HUCPV in the conditioned media system. (a) Live/dead 
staining of HUCPV. The green and red spots represent live and dead cells, respectively. (b) 
The DNA content of HUCPV. The scale bar represents 500 μm. The bars represent the mean 
± SD (n≥12). The asterisks represent significant differences between the two conditions 
(ANOVA; α=0.05). H: HUCPV; P: PBMC; CM: conditioned media. 
In the conditioned media system, PBMC growth up to 7 days is shown in Fig. 22. A large number 
of live cells (green) and a few dead cells (red) were observed (Fig. 22a). As shown in Fig. 22b, 
no significant differences in the proliferation of PBMC were observed among the Ctr (blank) 
and conditioned media following treatment with Mg, HUCPV, or both.  
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Fig. 22 Cell viability and proliferation of PBMC in the conditioned media system. (a) Live/dead 
staining of PBMC. The green and red spots represent live and dead cells, respectively. (b) The 
DNA content of PBMC. The scale bar represents 200 μm. The bars represent the mean ± SD 
(n≥12). The asterisks represent significant differences between the two conditions (ANOVA; 
α=0.05). H: HUCPV; P: PBMC; CM: conditioned media. 
5.1.3.  Cytokine release in the transwell coculture system 
The inductive or suppressive roles of MSC in inflammation can be mediated by Mg or immune 
cells (PBMC, macrophages, etc.). Additionally, migration-related factors contribute to the 
recruitment of cells to damaged sites to participate in wound healing.  
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To determine the influence of the Mg biomaterial on the cell-cell communication mediated by 
soluble factors, cytokine release in the supernatant of all treatment conditions in the transwell 
coculture system was measured via a multiplex assay. A panel of targets (Table 11) was utilised 
to investigate selected inflammatory cytokines at the protein level.  
These cytokines can be classified into several functional groups:  
(a) pro-inflammatory: IL1β, IL2, TNFα and IFNγ; 
(b) anti-inflammatory: IL4, IL5, IL13, G-CSF, IL10 and IL1RA (immunomodulation: IL10 and 
IL1RA); 
(c) migration/wound healing: GM-CSF, IL8, MCP-1 and MIP-1α/β.  
The data were calculated as the cytokine level (pg/mL) normalised by total DNA content (μg/mL) 
(Table 15). After comparing the cytokine levels between the conditions with and without Mg 
(+Mg vs. -Mg, respectively), the cytokine production fold change was quantified and 
summarised in Fig. 23. The results of the other cytokines are summarised in Table S1.  
As shown in Fig. 23, decreased levels of pro-inflammatory proteins (IL2, TNFα, IL1β, and IFNγ) 
and increased production of anti-inflammatory (IL13 and G-CSF) cytokines were observed in 
HUCPV in contact with Mg. Thus, Mg may induce HUCPV into an anti-inflammatory state. 
Initially, the PBMC were activated when cultured with Mg (day 1), expressing high levels of all 
the above cytokines; however, when the PBMC were cocultured with HUCPV, a downregulation 
of the pro-inflammatory factors IL2, TNFα, and IFNγ (fold change -5 to -10) at day 4, as well as 
an increase in the anti-inflammatory factors IL13 and G-CSF (fold change 5 to 10) at day 7 
were observed (Fig. 23). A similar increase in IL4/5 following Mg exposure was also observed 
in the PBMC. A clear decrease in IL4/5 caused by Mg appeared in the cocultures. Moderate 
inflammation was observed when the HUCPV mediated Mg-induced cytokine production in the 
PBMC. 
Taken together, these results indicate that when exposed to Mg, HUCPV can create an anti-
inflammatory microenvironment. Furthermore, HUCPV play a role in the suppression of Mg-
induced inflammatory cytokine production in PBMC. This immune-modulation of HUCPV on 
PBMC/macrophage behaviour is dominated by the immunomodulatory characteristics of 
HUCPV [207, 208]. 
To elucidate the influence of Mg (+/-PBMC) on MSC migration into the injury in vitro, a multiplex 
assay of migration/wound healing-related cytokines (IL8, GM-CSF, MCP-1 and MIP-1α/β) was 
performed and showed an increase regardless of cell type (HUCPV, PBMC, and HUCPV 
cocultured with PBMC) exposed to Mg compared to the control group without Mg (Table 15).  
Also, as summarised in Fig. 23, PBMC exhibited a more robust production of GM-CSF, IL8, 
MCP-1 and MIP-1α/β after Mg exposure. On both days 1 and 7, PBMC exhibited a higher 
production of GM-CSF, IL8, MCP-1 and MIP-1α/β after Mg exposure. These cytokines promote 
stem cells (HUCPV) to migrate into the injury site and are further involved in tissue repair 
processes [125, 209, 210]. 
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Fig. 23 The cytokine levels in the supernatant of HUCPV, PBMC and HUCPV-PBMC coculture 
in the presence and absence of Mg discs. The colour scale represents the fold change between 
the conditions with Mg discs and controls without Mg discs. The bars represent the mean ± SD 
(n≥12). The asterisks indicate significant differences between the two conditions (ANOVA; 
α=0.05, *P≤0.05, **P≤0.01 and ***P≤0.001). 
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Table 15 The levels of secreted cytokines (normalised by the total DNA content) in the 
supernatants in the transwell coculture system at days 1, 4 and 7. The cytokine level 
(pg/mL)/total DNA content (μg/mL) data were obtained from biological duplicates of three 
independent experiments from at least two donors of HUCPV (H) and PBMC (P), resulting in 
n≥12 (samples size). <<OOR represents “out of calibration range” in the multiplex 
immunoassay. H: HUCPV; P: PBMC. 
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Table 15 (Continued)  
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Table 15 (Continued)  
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5.1.4.  M2 macrophages polarisation  
PBMC are a cluster of immune cells that include granulocytes (neutrophils, basophils, and 
eosinophils), monocytes, and many lymphocytes (T cells, B cells, and NK cells). The 
subpopulation of each cell cluster in the isolated PBMC that were used in this study is shown 
in Fig. 24.  
During flow cytometric analysis, the cells pass through the beam and scatter light, which is then 
detected as forward scatter (FSC) and side scatter (SSC). FSC is related to cell size, and SSC 
provides information about the internal complexity (i.e., granularity) of a cell. In this way, one 
can often distinguish cell populations based solely on differences in cell size. Larger, more 
granular granulocytes produce a large population with high FSC and SSC. Monocytes are large 
cells, but not so granular, so they produce a separate population with high FSC but low SSC. 
Smaller, but non-granular lymphocytes produce a population with low FSC and low SSC. 
Therefore, these cells can be divided into different populations based solely on their FSC and 
SSC.  
Fig. 24 Subpopulations (%) of PBMC. The percentages of lymphocytes, monocytes and 
granulocytes in isolated PBMC were indicated via flow cytometric analysis. 
In addition to the multi-nuclear morphology of monocyte fusion, the cell phenotype of type 2 
macrophages (M2) during monocyte/macrophage differentiation was confirmed with flow 
cytometric analysis (Fig. 25). Here, the macrophage pan marker-CD 68+ was used to 
distinguish the macrophages from the PBMC cluster. Then, the surface antigen-CD 163+ was 
stained to classify the M2 subpopulation from all CD 68+ cells (all subtypes of macrophages). 
In Fig. 25, the percentage of M2 (CD 68+ CD 163+) at day 7 in the H+P+Mg conditions of the 
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transwell coculture system is shown. First, debris and dead cells were removed (positive 
propidium iodide (PI) staining). Then, CD 68+ cells (Fig. 25a, blue dots) were gated from the 
total cells. Finally, the profile shown in Fig. 25b was obtained, and the M2 macrophages in this 
CD 68+ subgroup were automatically calculated (approximately 60%).  
Fig. 25 Flow cytometric analysis of the M2 subpopulation. (a) The selection of macrophages 
(CD 68+). In brief, the live cells were first gated out, followed by the CD 68+ cells. (b) The 
selection of M2 macrophages in this CD 68+ subgroup. CD 163 was used as a specific marker 
to identify M2 macrophages from the total macrophage population.  
In PBMC, the monocytes differentiating into M2 macrophages were indicated by phenotypic 
changes after 1, 4 and 7 days detected via flow cytometry (Fig. 26). PBMC were labelled with 
anti-human CD 68+ (a pan marker for macrophages) and anti-human CD 163+ (surface marker 
for the M2 phenotype). 
Flow cytometry (Fig. 26a) revealed an elevated percentage of M2 macrophages in the total 
macrophage population at day 1 when PBMC were exposed to HUCPV (P vs. H+P). In addition, 
compared to the H+P condition, the M2/CD 68+ cell population increased under the H+P+Mg 
condition from day 4 onward. At day 7, Mg in synergy with HUCPV promoted the M2 
macrophage phenotype. Similarly, the M2/CD 68+ population increased in the conditioned 
media system (Fig. 26b) between P+(H CM) and P+(H+Mg CM) conditions after 1 day of culture. 
Additionally, a clear increase was observed under the conditions of P alone and P+(Mg CM) on 
day 4. These data suggest that this polarisation may derive from the effect of Mg on the 
immunomodulatory properties of HUCPV. 
The results also indicate the regulation of stem cells on M2 macrophage polarisation. For 
instance, an elevated percentage of M2 macrophages was exhibited at day 1 in both the 
transwell coculture (P and H+P) and conditioned media systems (P+(Mg CM) and P+(H+Mg 
CM)).  
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Compared to the role of HUCPV on the M2 phenotype, the effect of Mg on the M2 phenotype 
in different indirect coculture systems notably could be seen. Mg significantly elevated the M2 
phenotype in PBMC compared to HUCPV in either P+Mg vs. H+P (transwell coculture) or 
P+(Mg CM) vs. P+(H CM) in conditioned media system at day 4 or 7.  
Taken together, these data imply that Mg could promote macrophage differentiation into M2 
cells with and without HUCPV cell exposure. 
 
Fig. 26 The percentage of M2 cells in the total macrophage population in the transwell coculture 
and conditioned media systems. (a) M2 in transwell coculture. (b) M2 in conditioned media 
system. The bars represent the mean ± SD (n≥12). Significant differences are represented by 
asterisks and were obtained from post hoc multiple comparisons between each group or 
compared to controls in ANOVA (α=0.05, *P≤0.05). H: HUCPV; P: PBMC; CM: conditioned 
media. 
5.1.5.  Migratory ability of HUCPV  
Referring to the former section, migration-specific cytokines were significantly upregulated by 
Mg exposure. Thus, a scratch assay was performed to investigate the migration potential of 
HUCPV upon stimulation with PBMC and/or Mg discs under physiological conditions. 
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Fig. 27 The migration distance of HUCPV when cultured in the supernatant from the transwell 
coculture system. (a) The scratches at 0 h and 24 h were quantified by the gap width. (b) 
HUCPV cell migration distance in the transwell coculture system. The scale bar represents 500 
μm. The migration distance was calculated by the scratch width difference between 0 h and 24 
h. The bars represent the mean ± SD (n≥12). Significance differences are represented by 
asterisks and were obtained from post hoc multiple comparisons between each group or 
compared to controls with ANOVA (α=0.05, *P≤0.05). H: HUCPV; P: PBMC. 
The migration distance of HUCPV was qualified by the scratch area difference between 0 and 
24 h (Fig. 27 and 28). As shown in Fig. 27b, compared to the α-MEM control group, treatment 
with Mg or PBMC (P) or both (P+Mg) significantly increased the migratory ability of HUCPV. 
Similarly, a stimulated migration capacity of HUCPV was observed in P+Mg compared with 
HUCPV in P. In the captured bright light micrographs, a large number of HUCPV crossed the 
edge of the scratch in the transwell coculture after 24 h (Fig. 27a). These results reveal that 
HUCPV have a greater capacity to migrate when cultured with Mg and/or PBMC for 24 h in the 
transwell coculture system. 
No difference was observed when HUCPV were cultured in the conditioned media system of 
all experimental conditions (Fig. 28). Interestingly, Mg stimulated HUCPV cell migration 
capacity in the transwell coculture system but not in the conditioned media system. This 
difference may be due to the various Mg concentrations of the Mg group in the transwell 
coculture and conditioned media systems. The Mg group contained 8 mM or 3.8 mM Mg ion in 
the transwell coculture or conditioned media system, respectively.  
Therefore, the significantly increased migration of HUCPV may be influenced by the Mg 
concentration itself.  
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Fig. 28 The migration distance of HUCPV when cultured in the supernatant from the conditioned 
media system. (a) The scratches at 0 h and 24 h were quantified by the gap width. (b) HUCPV 
cell migration distance in the conditioned media system. The scale bar represents 500 μm. The 
migration distance was calculated by the scratch difference between 0 h and 24 h. The bars 
represent the mean ± SD (n≥12). Significant differences were obtained from post hoc multiple 
comparisons in ANOVA (α=0.05). H: HUCPV; P: PBMC; CM: conditioned media. 
5.1.6.  Osteogenic potential of HUCPV 
ALP activity acts as an indicator of HUCPV cell osteogenic differentiation. ALP activity at day 7 
can be attributed to HUCPV as the PBMC/macrophages do not significantly produce ALP 
activity [211]. Hence, only treatment conditions involving HUCPV are presented to indicate 
HUCPV differentiation: H, H+Mg, H+P, H+P+Mg in the transwell coculture system (Fig. 29a and 
30a) and H, H+(Mg CM), H+(P CM), H+(P+Mg CM) in the conditioned media system (Fig. 29b 
and 30b).  
The ALP activities were normalised to the respective DNA contents of the HUCPV to reduce 
variation induced by proliferation. The ALP activities at day 7 can be attributed to HUCPV as 
the PBMC/macrophages do not significantly produce ALP [211].  
In the transwell coculture system, when HUCPV were exposed to Mg or PBMC+Mg (Fig. 29a), 
significantly increased ALP activity was observed compared to HUCPV cell monoculture in the 
control cell culture medium. The ALP level of PBMC on inserts (H+P) was not affected; however, 
in the presence of Mg discs (H+P+Mg), ALP activity was significantly upregulated. In the 
conditioned media system (Fig. 29b), no difference in ALP activity between the controls 
(HUCPV monoculture) and other treatments was measured. 
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Fig. 29 The osteogenic potential of HUCPV indicated by ALP activity in the transwell coculture 
and conditioned media systems at day 7. ALP activity in the transwell coculture (a) and 
conditioned media systems (b) was normalised by the respective HUCPV DNA content. The 
bars represent the mean ± SD (n≥12). Significant differences are represented by asterisks and 
were obtained from post hoc multiple comparisons between each group or compared to controls 
with ANOVA (α=0.05, *P≤0.05). H: HUCPV; P: PBMC; CM: conditioned media. 
In addition, the fold change of osteogenesis-related gene expression of COL1A1, OC and OPN 
in HUCPV is indicated by the colour scale in Fig. 30a and 30b.  
In the transwell coculture system, the coculture with PBMC enhanced the expression of OC in 
HUCPV. Similarly, increases in COL1A1, OC and OPN were found when Mg was applied. Even 
a synergistic effect of P and Mg could be seen for OC (regulation fold reached 20). 
In the conditioned media system, COL1A1 and OPN were upregulated in all coculture groups, 
accompanied by a slight decrease in OC expression in (H+P+Mg CM). A higher fold change 
was observed for the COL1A1 gene (regulation fold from 8.5 to 11.0). 
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Fig. 30 Osteogenesis-related gene expression in transwell coculture and conditioned media 
system at day 7 in HUCPV was measured by RT-qPCR. The gene expression fold change was 
compared to controls (H) in transwell coculture (a) and conditioned media system (b). The bars 
represent the mean ± SD (n≥12). Significant differences are represented by asterisks and were 
obtained from post hoc multiple comparisons between each group or compared to controls with 
ANOVA (α=0.05, *P≤0.05, **P≤0.01 and ***P≤0.001). H: HUCPV; P: PBMC; CM: conditioned 
media. 
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5.2.  Interactions between macrophages and HUCPV in a direct coculture 
system  
5.2.1.  Mg concentration, pH, osmolality, and corrosion rate characterisation 
To characterise the experimental conditions, the Mg concentration, pH, osmolality and 
corrosion rate of the supernatants at each time point were analysed. Because of the 
degradation of Mg and Mg-10Gd over time, the specimen characterisation under different 
conditions of a direct coculture system was determined at days 7 and 14 (Table 16). 
Table 16 The Mg concentration, pH, osmolality and corrosion rate characterisation of the 
solutions for all experimental conditions in the direct coculture system. The blank group at day 
0 was also characterised (Mg concentration: 0.71 mM; pH: 7.60; osmolality: 0.31 Osmol/kg). 
The data were obtained from biological duplicates of three independent experiments, resulting 
in a sample size of n=6. H: HUCPV; M: macrophages. 
Timepoints Conditions 
Mg 
(mM) 
pH 
Osmolality 
(Osmol/kg) 
Corrosion 
rate (mm/y) 
Day 7 
H 0.57±0.12 8.15±0.03 0.33±0.01 / 
H+M 0.41±0.01 8.18±0.03 0.34±0.01 / 
H+Mg 30.36±5.41 8.46±0.14 0.40±0.01 1.16±0.24 
H+M+Mg 23.59±1.62 8.44±0.02 0.40±0.02 1.31±0.28 
H+Mg-10Gd 16.31±3.38 8.55±0.02 0.38±0.01 1.29±0.03 
H+M+Mg-10Gd 15.87±1.05 8.53±0.04 0.38±0.01 1.31±0.01 
Day 14 
H 0.45±0.01 8.20±0.02 0.35±0.04 / 
H+M 0.40±0.01 8.19±0.03 0.34±0.01 / 
H+Mg 35.26±9.11 8.46±0.01 0.41±0.02 0.73±0.06 
H+M+Mg 29.76±0.65 8.46±0.06 0.40±0.02 0.63±0.07 
H+Mg-10Gd 16.33±0.75 8.50±0.04 0.36±0.01 0.69±0.03 
H+M+Mg-10Gd 18.30±1.95 8.50±0.02 0.36±0.01 0.59±0.04 
In the direct coculture system, the Mg concentration in the blank group at day 0 was 0.71 mM. 
The Mg concentration under conditions without an Mg disc ranged from 0.40 to 0.57 mM. 
Different Mg concentrations were measured upon treatment with Mg or Mg-10Gd in cell-seeded 
conditions. The Mg concentration in cell-seeded conditions (i.e., H+Mg, P+Mg and H+P+Mg) 
ranged from 23.59 to 35.26 mM at various time points. The Mg concentration in those cell-
seeded conditions with Mg-10Gd dropped from 15.87 to 18.30 mM.  
As shown in Table 16, the pH value varied from 8.44 to 8.55 in the presence of Mg or Mg-10Gd 
at day 7. The pH value under each condition was clearly higher compared to the blank group 
(pH: 7.60).  
Under different conditions of the direct coculture system, the osmolality in the supernatants 
ranged from 0.33 to 0.41 Osmol/kg (osmolality in blank group: 0.31 Osmol/kg). 
Consistently, both the Mg- and Mg-10Gd-treated groups showed a higher corrosion rate of 
approximately 1.30 mm/y before 7 days. Up to 14 days, the corrosion rate slowed to 
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approximately 0.70 mm/y. At the same timepoint, no significant differences in the corrosion rate 
between Mg and Mg-10Gd were found.  
5.2.2.  Cell viability and proliferation 
To determine the roles of the Mg disc on cell viability and proliferation, live/dead staining (Fig. 
31) and DNA content (Fig. 32) of HUCPV/macrophages were investigated in direct coculture 
systems. After staining, the live cells were labelled green, while the dead cells were red. Cell 
proliferation, indicated by the DNA content, shows the cell number in mono- and co-culture with 
Mg or Mg-10Gd at various timepoints (days 7 and 14). 
Fig. 31 Live/dead staining of HUCPV alone or cocultured with macrophages at days 7 and 14. 
The scale bar represents 1000 μm. 
As shown in Fig. 31, in a direct coculture system, adherent HUCPV and cocultured HUCPV-
macrophages could be observed in blank (Ctr), Mg and Mg-10Gd wells during the entire culture 
period. The numbers of dead (red) and live cells (green) in the HUCPV monocultures in control 
wells and HUCPV cell-macrophage cocultures were not affected by the presence of Mg or Mg-
10Gd.  
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Comparing Mg and Mg-10Gd (Fig. 32), no difference was found for cell growth. At days 7 and 
14, the cell monoculture and cocultures in the controls exhibited a consistent DNA content 
(approximately 5 μg/mL). Even though the materials reduced the DNA content at day 7, a 
recovery of HUCPV proliferation was observed at day 14, especially with Mg-10Gd. 
Fig. 32 The DNA content of HUCPV alone and in coculture with macrophages at days 7 and 
14. The bars represent the mean ± SD (n≥12). Significant differences are represented by 
asterisks and were obtained from post hoc multiple comparisons between each group or 
compared to controls with ANOVA (α=0.05, *P≤0.05, **P≤0.01 and ***P≤0.001). 
5.2.3.  Subpopulations of HUCPV cell and macrophage cocultures 
Fig. 33 The cell distribution in the direct coculture groups at days 7 and 14. The histograms 
represent HUCPV (blue) and macrophages (red).  
As shown in Fig. 33, HUCPV were confirmed as CD 90 positive while macrophages did not 
express the CD 90 antigen during the culture period. Immunophenotyping analysis utilising the 
CD 90 marker was applied to reveal the cellular proportion of HUCPV and macrophages in 
direct coculture upon stimulation by materials. 
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Comparing the groups exposed or not to Mg or Mg-10Gd, no significant effects were found on 
the cell ratios after 14 days (Fig. 34). This result implies that the cell ratios should not be 
considered as a parameter that could either influence cell-cell direct interactions or explain 
results.  
Fig. 34 Cell subpopulations (%) in the direct coculture groups at days 7 and 14. The bars 
represent the mean ± SD (n≥12). Significant differences were investigated by post hoc multiple 
comparisons between each group or compared to controls with ANOVA (α=0.05). 
5.2.4.  Mg and Mg-10Gd stimulated the pro-osteogenic activity of HUCPV 
Fig. 35 The ALP activity in HUCPV and cocultures. The ALP activity was normalised by the 
corresponding DNA content. The bars represent the mean ± SD (n≥12). Significant differences 
are represented by asterisks and were obtained from post hoc multiple comparisons between 
each group or compared to controls with ANOVA (α=0.05, *P≤0.05, **P≤0.01 and ***P≤0.001). 
As shown in Fig. 35, the ALP activities were markedly enhanced at day 7 by Mg and Mg-10Gd 
in both the HUCPV cell monoculture and cocultures. The stimulation by Mg-10Gd was more 
efficient than pure Mg. 
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Shown in Fig. 36, HUCPV cocultured with macrophages and/or Mg or Mg-10Gd expressed 
markedly higher levels of osteogenic-related genes. Specifically, the expression levels of ALP, 
OC and OPN were significantly higher under stimulation by Mg and Mg-10Gd in both the 
HUCPV cell monoculture or coculture systems. The RT-qPCR results showed that OC (fold 
change: 70) and ALP (fold change: 200) genes exhibited the highest expression upon 
stimulation by Mg in the cocultures. The expression of OPN was also significantly higher under 
stimulation by Mg-10Gd in both the HUCPV cell monoculture and cocultures. 
 
Fig. 36 Selected gene expression in HUCPV alone or in cocultures at days 7 and 14. The 
expression levels of ALP (a), COL1A1 (b), OC (c), and OPN (d) were investigated with RT-
qPCR. The “gene expression” on the y-axis defines the changes in the selected genes 
normalised to the levels of the reference genes. The bars represent the mean ± SD (n≥12). 
Significant differences are represented by asterisks and were obtained from post hoc multiple 
comparisons between each condition (α=0.05, *P≤0.05, **P≤0.01, and ***P≤0.001). 
5.2.5.  Possible signalling factors (OSM/IL6/BMP6/TNFα/IL1β) involved in the pre-
osteogenic activity of HUCPV 
Among the signalling factors secreted by macrophages, immune-regulatory cytokines have 
been extensively investigated. Members of the IL6 family (OSM) can stimulate bone formation. 
Acting as pro-inflammatory cytokines, TNFα and IL1β can modulate bone formation by 
inhibiting osteoblast differentiation. In addition, macrophages can also release growth factors, 
such as BMP. The involvement of BMP has also been reported to have a stimulatory effect on 
bone formation.  
To confirm the involvement of these signalling factors on the pro-osteogenic activity of HUCPV, 
the levels of OSM, IL6, TNFα, and IL1β were measured by ELISA. The related gene expression 
of the BMP/Smad signalling pathway members was also studied. 
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5.2.5.1.  The effects of OSM/IL6 on osteogenic behaviour are OSM- and gp130-dependent 
Fig. 37 The OSM and IL6 levels in the supernatant of cocultured HUCPV and macrophages in 
a direct culture on metallic biomaterial. The bars represent the mean ± SD (n≥12). Significant 
differences are represented by asterisks and were obtained from post hoc multiple comparisons 
between each group or compared to controls with ANOVA (α=0.05, *P≤0.05, **P≤0.01 and 
***P≤0.001). 
The ELISA assays highlighted that extracellular OSM was significantly stimulated up to 14 days 
(Fig. 37a). At day 7, OSM was significantly higher in the presence of Mg and Mg-10Gd. The 
OSM level was also increased by coculture of HUCPV and macrophages. At day 14, OSM was 
significantly upregulated only in the cocultures, regardless of the presence or absence of Mg-
based materials. These results indicated that cocultures in synergy with materials (Mg and Mg-
10Gd) contributed to the higher secretion of OSM.  
As shown in Fig. 37b, no difference in the IL6 levels between HUCPV cell monoculture and 
cocultures in the controls was detected during the 14-day experiment. Even though a clear 
decrease was shown by both additives in the HUCPV cell monoculture or cocultures, 
nevertheless, in the cocultures, the reduced IL6 secretion was attenuated by both Mg-based 
materials. Taken together, these data show that the OSM and IL6 secretions are influenced by 
Mg-based (Mg and Mg-10Gd) materials, especially in the cocultures.  
To further investigate the OSM- [166] and IL6-mediated [160] osteoblastogenesis, OSM and 
gp130 were neutralised in the cell cocultures. After neutralisation, ALP activities in the 
cocultures were investigated.  
As shown in Fig. 38, the ALP activities in the cocultures were normalised by the corresponding 
DNA content. The neutralisation of OSM and OSM+gp130 significantly decreased the ALP 
activity in the cocultures exposed to the Mg disc at both days 7 and 14. When the cocultures 
were exposed to Mg-10Gd, the ALP activity was also reduced after anti-gp130 treatment, but 
this result was only statistically significant at day 7. In the isotype control groups, IgG1 and 
IgG2a, the ALP level was unchanged compared to the blank control group (only the cell 
cocultures). These results collectively indicate that the roles of OSM and IL6 on the osteogenic 
differentiation of HUCPV are OSM- and gp130-dependent. 
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Fig. 38 ALP activity after OSM and gp130 neutralisation in the cocultures at days 7 and 14. 
HUCPV and macrophages were cocultured (blank) and seeded on Mg or Mg-10Gd for 14 days 
and were treated with anti-OSM (0.2 μg/mL), anti-gp130 (0.2 μg/mL) or both antibodies. The 
condition without anti-OSM and anti-gp130 served as the control (Ctr). IgG1 and IgG2a were 
applied as isotype controls. ALP activity in the supernatant was assessed and normalised by 
the corresponding DNA content. The bars represent the mean ± SD (n≥12). Significant 
differences were investigated by ANOVA and indicated by an asterisk (α=0.05, *P≤0.05, 
**P≤0.01, and ***P≤0.001). 
5.2.5.2.  BMP6/Smad signalling is involved in the osteogenic differentiation of HUCPV 
The osteogenic mediation between HUCPV and macrophages requires signalling cascades 
such as BMP/Smad, which involves the receptors BMPR1A and BMPR2 as well as Smad 1/4/5. 
To follow this cascade, the expression of several factors including BMP6, BMPR1A/2 and Smad 
1/4/5 was measured via RT-PCR. As shown in Fig. 39, the gene expression of BMP6 in the 
macrophages was significantly upregulated by Mg (days 3, 7 and 14) and Mg-10Gd (days 7 
and 14).  
Fig. 39 BMP6 expression in macrophages under stimulation by Mg and Mg-10Gd. Control (Ctr): 
cell culture medium. The y-axis shows the change in the selected gene normalised to the level 
of the reference gene. The bars represent the mean ± SD (n≥12). Significant differences were 
investigated by t-test and are indicated by an asterisk (α=0.05, *P≤0.05, **P≤0.01 and 
***P≤0.001). 
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To confirm BMP6-related cascade involvement, the macrophages were cocultured with HUCPV 
for 14 days in a direct coculture system upon stimulation with Mg and Mg-10Gd.  
First, the expression of the receptors for BMP6, BMPR1A and BMPR2 in the HUCPV and 
cocultures was quantified using RT-qPCR (Fig. 40). A great increase in BMPR1A and BMPR2 
expression was measured upon the stimulation by materials during the culture period, even 
though there was a slight decrease at day 14 when the cocultures were exposed to Mg-10Gd. 
Moreover, a much greater expression of BMPR1A/2 in the cocultured cells was detected upon 
Mg stimulation but not in those seeded on Mg-10Gd. 
 
Fig. 40 BMPR1A and BMPR2 expression in HUCPV and cocultures under stimulation of Mg 
and Mg-10Gd. The y-axis represents the change in the selected gene normalised to the level 
of the reference gene. The bars represent the mean ± SD (n≥12). Significant differences were 
investigated by ANOVA and are indicated by an asterisk (α=0.05, *P≤0.05, **P≤0.01 and 
***P≤0.001). 
To further explore the signalling mechanisms behind the osteogenic stimulation, the BMP-
related Smad genes, Smad1, 4 and 5, were also analysed (Fig. 41).  
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A similar increase was detected in HUCPV and cocultures in the presence of Mg and Mg-10Gd. 
The cell cocultures exposed to the Mg discs showed the highest gene expression of Smad1/4/5 
at day 14. 
 
Fig. 41 Smad 1/4/5 expression in HUCPV and cocultures under stimulation by Mg and Mg-
10Gd. The y-axis represents the change in the selected gene normalised to the level of the 
reference gene. The bars represent the mean ± SD (n≥12). Significant differences were 
investigated by ANOVA and are indicated by an asterisk (α=0.05, *P≤0.05, **P≤0.01 and 
***P≤0.001). 
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5.2.5.3.  Inflammatory cytokines (TNFα and IL1β) contributed to the osteogenic activity of 
HUCPV 
Fig. 42 TNFα and IL1β levels in the monoculture and cocultures. The bars represent the mean 
± SD (n≥12). Significant differences were investigated by ANOVA and are indicated by an 
asterisk (α=0.05, *P≤0.05, **P≤0.01 and ***P≤0.001). H: HUCPV; M: macrophages. 
The ELISA results indicated a greater inflammatory TNFα release by macrophages compared 
to HUCPV especially at day 3 (Fig. 42); however, compared to macrophages alone in the Ctr 
groups, the cocultures presented different effects on the TNFα level including a significant 
decrease in TNFα at day 3 but an increase at day 7. In both the macrophage monoculture and 
the cocultures, the materials (Mg and Mg-10Gd) reduced TNFα during the early culture period, 
especially the pure Mg at day 3.  
The secretion of IL1β from both the HUCPV cell and macrophage monoculture remained 
constant. A remarkable increase in the IL1β level was measured in the HUCPV cell and 
macrophage coculture at day 14. Nevertheless, consistent with the effects measured for TNFα, 
the IL1β level in the cocultures was reduced by Mg and Mg-10Gd at day 7, and this decrease 
by Mg was still observed at day 14.
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6. Discussion 
Mg-based biomaterials have been extensively studied in regenerative medicine, and tissue 
engineering and repair in this context depend on their excellent manufacturing and 
biocompatibility. To develop these promising implants for clinical trials, their biological activity 
must be clearly understood. 
In view of the complexity of local in vivo protagonists, a biomaterial triggers host immune 
reactions after implant prior to MSC recruitment [19, 212]. MSC can interact with immune cells 
by modulating immune responses and promoting bone regeneration (osteo-
immunomodulation); indeed, MSC and immune cells can share secreted cytokines [187, 213]. 
In addition, immune responses can affect the mechanical properties and performance of 
biomaterial [214]. However, comprehensive knowledge of the effects of degradable Mg on 
paracrine signalling between immune cells (PBMC/macrophages) and MSC remains lacking. 
Thus, the roles of degradable Mg in the immunomodulatory properties of MSC and immune-
mediated MSC behaviour, such as MSC migration and osteogenic differentiation, were studied. 
Furthermore, the underlying mechanisms of MSC differentiation into osteoblasts-like cells were 
studied. 
Tissue repair cells, immune cells, and Mg ions are three protagonists involved in the cascades 
of degradable Mg-modulated fracture healing. HUCPV are defined as mesenchymal progenitor, 
multipotent and allogeneic stem cells [203]. Compared to bone marrow mesenchymal stem 
cells (BMMSC), HUCPV, as an alternative foetal MSC, possess differentiation capacity and 
immunomodulatory properties as well [203, 215-217]. Macrophages are one of the key types 
of immune cells (PBMC) that participate in fracture healing given their polarisation plasticity 
[84]. Mg and Mg-based alloys are potential degradable materials for regenerative applications 
[218-220]. In the current study, initially pure Mg was selected to avoid an increase in biological 
complexity due to alloying elements. To widely evaluate the roles of Mg-based biomaterials in 
osteoblastogenesis, Mg-10Gd, which exhibits good physically properties, was also applied. 
To elucidate the interaction between MSC and immune cells, cocultures are widely applied. In 
the present study, we successfully established indirect in vitro coculture in a transwell coculture 
and conditioned media system. In the transwell coculture system, PBMC were typically seeded 
on the top of chamber, and HUCPV were seeded in the lower compartment. Cell-cell contact 
was avoided, allowing monocytes to differentiate into macrophages and HUCPV to differentiate 
into osteoblast-like cells. Thus, the individual cell type can be evaluated (individual cell 
proliferation, microscopic examination and gene expression). Moreover, in transwell coculture, 
interactions between various cell subtypes exist. In addition, MSC can influence various 
pathways of the immune responses in a paracrine manner [187, 188], so a conditioned media 
system should be applied. Regarding our conditioned media system, HUCPV-conditioned 
media were utilised to examine direct M2 differentiation, whereas PBMC-conditioned media 
induced HUCPV towards a pro-calcific phenotype. Together, these two systems were feasible 
to mimic the initial inflammation stage (up to 7 days) of Mg-modulated fracture healing. To 
evaluate the roles of Mg and Mg-10Gd in the following inflammation stage (7-14 days) of 
fracture healing, a direct coculture system was applied. HUCPV mono- and cocultured with 
macrophages were separately seeded on Mg/Mg-10Gd. Both cell types could communicate 
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with each other via autocrine or paracrine signalling. Here, a direct coculture system was used 
to mimic the subsequent in vivo phenomenon. In addition, as reported, the osteoblastogenesis 
process of MSC relied on physical interactions with monocytes or macrophages via direct cell-
cell contact [165]. In addition, auto/paracrine signals can also be analysed. 
As indirect in vitro models, results from conditioned media system and transwell coculture were 
not comparable given their distinct procedures, various conditions (Mg contents and cytokine 
levels) and particular purposes. As summarized in Fig. 43, more significant differences in cell 
behaviour were exclusively noted in the transwell coculture system. To be specific, conditioned 
media system was a static process, whereas transwell coculture was relatively dynamic. For 
instance, Mg concentrations were normally 3-4 mM in conditioned media system but varied 
from 0.5 mM to 18 mM in transwell coculture as a consequence of Mg degradation. Moreover, 
in transwell coculture, the participants were consistently communicating with each other. Hence, 
as a more suitable indirect system for the evaluation of osteo-immunomodulation [197], 
transwell coculture is highly relevant for microenvironment studies and allows in-depth tracking 
of the effects of biodegradable Mg on cell-cell interactions in the initial inflammation stage of 
biomaterial-mediated fracture healing. In addition, compared to indirect cocultures, higher Mg 
contents and pH but inconstant osmolarities were observed when cells and materials were 
cocultured together (direct coculture) in the late inflammation stage.  
After fracture, osteogenesis is one of the key processes of fracture healing. This process could 
be affected by its local environment (e.g., paracrine signalling) and the inflammatory response. 
The immune response is accompanied by tissue repair reactions in the following 2-10 days [19]. 
Osteogenesis relies on the good performance of MSC through proliferation and differentiation 
of osteoblasts. Additionally, clinical tests revealed that the success of MSC-based 
immunomodulation relies on the assessment of molecule secretion and their interaction with 
immune cells [213]. Multiple auto/paracrine signalling pathways work closely to modulate 
osteogenesis.  
Bone regeneration is a complex and well-organized physiological process of osteogenesis that 
remains a medical challenge in the field of orthopaedic surgery. In vitro evaluations of Mg-based 
biomaterials generally focus on several areas: cell growth and cell maturation (activation or 
differentiation). The current study also provides insight into the development of Mg-based 
biomaterials in osteogenesis and bone regeneration. This study consists of cellular 
mechanisms (paracrine signalling), biological therapies (osteo-immunomodulatory properties 
of MSC and paracrine secretions of inflammatory factors and growth factors), and tissue 
engineering approaches stimulating bone regeneration by targeting osteoblastogenesis 
through the interactions between MSC and immune cells. 
6.1.  HUCPV and immune cell growth correlates with Mg contents as well 
as physiological osmolality and pH 
The environment significantly influences the degradation behaviour of various materials. 
Furthermore, the physiological environment is rather corrosive. Components (e.g., serum) in 
body fluids are able to adsorb onto the material’s surface and subsequently affect the corrosion 
behaviour and cell attachment on Mg implants, thus further conditioning the fate of the implant 
[221]. Considering the ideal medium for growth of both cells (PBMC/macrophages and HUCPV), 
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α-MEM medium with human blood serum (plasma) or FBS was applied to prevent variance in 
medium components. In the current studies, pure Mg and Mg-10Gd discs were preincubated 
in medium with FBS, and improved cell adhesion and viability were observed as other reported 
[222]. The present results suggest various roles of degradable Mg in stromal and immune cells, 
such as HUCPV (MSC) and PBMC, and further differentiated macrophages in different in vitro 
systems. 
Viability measurements are used to determine the cytotoxicity of immune cells that respond to 
the material. If the cell response is poor and the viability is reduced, the biomaterial may not be 
able to support optimal wound healing in the body. Conversely, a significant increase in the 
viability of immune cells may not be the best result, likely indicating a certain degree of 
activation of the material [223]. Therefore, the use of immune cell viability as a single method 
for determining immune response may not be the best method for determining in vivo 
acceptance. In addition, cell proliferation was also used to evaluate cell growth. 
Such unstable physical factors could increase cell viability in transwell coculture but suppress 
them in cell-materials direct coculture. Similarly, DNA contents exhibited the same trend, e.g., 
higher anti-proliferous effects were measured in the direct coculture system. Taken together, 
different in vitro systems contributed to various physical microenvironments, resulting in the 
growth of various cells. 
In most mammalian cells, the total concentration of cellular Mg ranges from 17 to 20 mM [224], 
and concentrations in serum range between 0.65 and 1.05 mM [225]. In our system, the Mg 
concentration in cell culture medium (α-MEM) was 0.71 mM, which is consistent with the 
supplier’s information. Moreover, many cells maintain Mg at a physiological level, which is 
irrelevant to extracellular Mg concentrations [74]. In addition, Mg2+ is an important regulator of 
biological reactions because it is similar to other biologically important metal ions, such as Ca2+ 
and zinc (Zn)+ in terms of radius, coordination sphere [226], and soft and hard properties of 
boundaries [227-229]. In addition, Mg2+ is most likely to replace other metal ions in functional 
biomolecules, such as enzyme cofactors or enzymes that affect DNA activity [230, 231]. 
As summarised in the published literature, Mg plays various roles in cell growth, including 
stimulation of cell proliferation [75] or inhibition of cell number [76]. For instance, in U2OS cells, 
an osteosarcoma cell line, a slight inhibition of cell proliferation was observed with Mg 
concentrations greater than 5 mM [77]. Other studies suggested Mg significantly inhibits cell 
growth in the range of 12.5 to 50 mM [78-82]. As shown in Fig. 19 in transwell coculture, HUCPV 
exhibit reduced DNA content in presence of Mg (13.81 mM), whereas increased DNA content 
in HUCPV was observed upon exposure to Mg and P+Mg (5.74 mM and 17.91 mM). In addition, 
various Mg contents ranging from 0.54 to 17.91 mM promoted PBMC proliferation. 
Nevertheless, there was no clear difference in presence of Mg in the conditioned media system 
(Mg: 0.63 to 3.82 mM) regardless of the cell subtype (Fig. 20). Again, as shown in Fig. 32, a 
significant decrease of DNA contents caused by Mg was noted up to 14 days in a direct 
coculture system (Mg: approximately 30.00 mM). Viability staining demonstrated that cells were 
able to grow and proliferate on the materials present in these three in vitro systems. The 
influence of Mg on proliferation was attributed to the chemical properties of metal ions, which 
are related to molecular or biological activities. The differences in various models, conditions 
and time points are potentially caused by other metal ions present in metabolic enzymes or 
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DNA enzymes, such as Ca and Zn [226-229]. Magnesium ions can affect cell proliferation by 
displacing other ions from their biological functional molecules, thereby interfering with, for 
example, enzyme cofactors [230, 231]. Thus, the effects of Mg on cellular proliferation could be 
biphasic [83] or dependent on the microenvironment between materials and cells. 
To meet cell culture standards, the physiological osmolality should be around 0.29 Osmol/kg 
[232]. Cecchinato et al. (2015) noted a reduction in viability after cells were seeded on 
specimens probably due to changed surface properties and microenvironments (pH and 
osmolality) [233]. Here, the direct system exhibited a higher osmolality (0.36-0.41 Osmol/kg) in 
cell monoculture or coculture on the material’s surface. Thus, the increased osmolality due to 
Mg-induced cell-material contact may explain the decrease in HUCPV and/or PBMC growth in 
the presence of degradable Mg or Mg-10Gd. 
Changes in pH values exert remarkable influences on cell metabolic activity. In transwell 
coculture, conditioned media system, and direct coculture, pH values were slightly alkaline (8.0 
and 8.6). Some results support the advantageous effects of pH greater than 9.0 on cell viability 
[234, 235]. Furthermore, alkalosis was reported to increase osteoblastic formation in vivo [236]. 
In addition, an opposite stimulatory effect on cell viability was observed for pH values greater 
than 8.5 [237]. Hence, pH guides the microenvironment and subsequently influences the growth 
of bone-forming MSC and regulatory immune cells. In addition, a higher pH was noted in 
HUCPV and PBMC cocultured in the presence of an Mg disc at days 1 and 4. Under the present 
circumstances, the high pH could also enhance osteogenic differentiation. Previously, D.A. 
Bushinsky et al. (1983) suggested that a higher pH can induce Ca2+ influx to stimulate bone 
formation [238]. In addition to the new bone formation, an increased initial microenvironment 
pH in vivo is associated with a later response in TRAP (tartrate-resistant acid phosphatase)-
positive osteoclast-like cells [239]. These results suggest that Mg material-mediated pH 
variation may play a role in osteogenic activity in the current study. 
6.2.  Interactions between PBMC/macrophages and HUCPV in indirect 
coculture (transwell coculture and conditioned media) system  
Based on the current results of interactions between PBMC/macrophages and HUCPV in the 
indirect coculture system (transwell coculture and conditioned media system), the possible 
roles of degradable Mg on the interactions between immune cells and HUCPV in transwell 
coculture and conditioned media system are presented in Fig. 43. 
The obvious difference caused by Mg and/or immune cells is described in detail as followings:  
l Roles of degradable Mg in immunomodulatory properties of HUCPV (in section 6.2.1.); 
1) Synergetic effects of Mg and HUCPV on attenuating inflammation via a moderate 
inflammatory cytokine production in a transwell coculture system; 
2) Synergetic effects of Mg and HUCPV on enhancing M2 macrophages phenotype in 
PBMC in the transwell coculture and conditioned media system. 
l Roles of degradable Mg in inflammatory secretion-mediated fracture healing (in 
sections 6.2.2. and 6.2.3.). 
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1) Synergetic effects of Mg and PBMC on stimulating the migratory ability of HUCPV in 
a transwell coculture system; 
2) Enhanced pro-osteogenic potential of HUCPV by Mg but not PBMC in a transwell 
coculture system. 
 
Fig. 43 Possible roles of degradable Mg on the interactions between immune cells and HUCPV 
in a transwell coculture and conditioned media system. TW: transwell system; CM: conditioned 
media. 
6.2.1.  Inflammation 
Immune rejection has become a common and end result of the clinical use of popular biological 
materials. The immune response is caused by the biomaterial’s interaction with the immune 
system, which includes innate and adaptive responses. The innate response includes a wide 
variety of cells, such as polymorphonuclear cells (granulocytes, eosinophils, and basophils), 
mononuclear phagocytes (dendritic cells, monocytes and macrophages) and lymphocytes (NK 
cells, gamma delta T cells and innate lymphoid cells), whereas the adaptive response includes 
T and B lymphocytes [240]. The immune response to a biomaterial typically comprises non-
specific inflammation [241]. PBMC have been widely used as immune cells to evaluate the in 
vitro inflammatory reaction to biomaterials [242, 243]. PBMC consist of lymphocytes (T cells, B 
cells, NK cells) and monocytes (10-20 %).  
Recent studies based on protein secretions tend to use multiple kits to measure several 
markers of immune cell activation. The advantage of this technique is that it can provide 
information on the levels of protein secretion associated with pro-inflammatory and anti-
inflammatory properties. Therefore, the information obtained from multiple markers, such as 
multiplex immunoassays, provide more clear information to predict the in vivo immune 
acceptance of a biomaterial. 
As an in vitro model of the initial immune reaction after biomaterial implantation, secretion of 
cytokines by PBMC could be instructive. In vitro secretion of cytokines by PBMC could serve 
as a measurement of their activation after in vivo implantation. PBMC are able to secret a broad 
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series of cytokines in non-specific inflammatory responses, including pro-inflammatory IL1β, 
IL2, TNFα, and IFNγ [244], as well as anti-inflammatory cytokines, such as IL10 [245]. 
Additionally, immune cell activation mainly focuses on the assessment of secretion of specific 
cytokines. This is a common method used to characterise the in vitro immune response to a 
biomaterial. Therefore, PBMC were isolated from blood, and released cytokines were 
measured after 1, 4, and 7 days to follow the initial immune reaction to Mg degradable material. 
For instance, a high pro-/anti- ratio indicates that the material may cause a serious foreign body 
reaction, and a high anti-/pro- ratio is associated with pro-healing processes in the body [246, 
247]. Common cytokines have been used to evaluate the immune acceptance or rejection for 
a biomaterial.  
Cytokines were investigated using an in vitro indirect system-transwell coculture system. In this 
cell-cell noncontact model, HUCPV and PBMC were seeded on the material’s surface or inserts, 
respectively, in the upper chamber. Monocytes (PBMC) can activate and differentiate into 
macrophage phenotypes. Meanwhile, without competition for a well’s surface, HUCPV can 
proliferate and/or differentiate into osteoblast-like cells. In addition to preventing cell-cell 
physical contact, the membrane of transwell coculture allows secretory factors transfer and 
communication between these two cell types. A previous transwell coculture study reported that 
the influence of cytokine secretion can be observed between macrophages and MSC [84].  
After infiltrating onto injurious tissue or the material’s surface, monocytes can be stimulated to 
secrete cytokines, chemokines and other soluble factors to contribute to injurious tissue repair 
[248]. Once recruited to targets, monocytes can differentiate into macrophages. The main 
subtypes of macrophages are M1 and M2 phenotype macrophages, which are vital factors in 
the resolution of inflammation and tissue remodelling [249-251]. Macrophages are essentially 
phagocytic and have specific phenotypic characteristics. Macrophages are a group of 
differentiated immune cells and are polarized by various microenvironments to generate 
heterogeneous populations with different characteristics and functions. Macrophages are 
involved in tissue homeostasis, immune reactions and wound healing.  
M1 phenotype macrophages are often induced by TLR ligands or T helper type 1 (Th1) 
cytokines (TNFα and IFNγ) [252]. These macrophages release cytokines, such as IL6, IL12, 
and TNFα, which are associated with pro-inflammatory activities [253]. In addition, M2 
phenotype macrophages are polarized by Th2-derived cytokines, including IL4, IL10, IL13, 
TGFβ or prostaglandin E2 (PGE2) [252]. They are called “tissue repair macrophages” because 
they promote tissue repair through immune tolerance and tissue remodelling, removal of debris, 
and immune regulation [254]. Regarding implant-mediated fracture healing, M2 macrophages 
also secrete VEGF to support angiogenesis and express immunosuppressive molecules, such 
as IL10 and IL1RA, which are conducive to the resolution of inflammation [223]. The M2 
phenotype has three subtypes: allergic M2a, immune-regulatory M2b, and wound-healing M2c 
[255, 256]. Despite their importance, M2a and M2b types have a smaller role in biocompatibility 
assessment. M2c has anti-inflammatory effects and promotes wound healing, extracellular 
matrix deposition, and tissue remodelling [257, 258]. Additionally, pro-inflammatory secretions 
of IL1β, IL6, IL8 and TNFα defined the pro-inflammatory response, whereas anti-inflammatory 
TGFβ, IL4, IL10, IL13 and IL1RA exhibit anti-inflammation and wound healing activities [257, 
258].  
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In the host immune response after Mg implantation, secretory cytokines are vital players in the 
regulation of inflammation. Given the pro- and anti-inflammatory properties of MSC and 
PBMC/macrophages [259, 260], this correlation was evaluated via the production of cytokines 
in the inflammatory panel (TNFα, IFNγ, IL1β, IL2, IL4, IL5, IL10, IL13, IL1RA, and G-CSF) in 
the current transwell coculture system. In the presence of Mg, HUCPV secreted reduced 
amounts of pro-inflammatory TNFα, IFNγ, IL1β, and IL2 on day 4 when the Mg concentrations 
in supernatants reached 18 mM. Moreover, at days 1 and 7 (Mg concentrations range from 5 
and 8 mM), Mg-stimulated PBMC exhibited an intensive inflammation state, releasing higher 
levels of pro- and anti- inflammatory cytokines; this stimulation is potentially recognised by an 
inflammatory response and cell activation [31]. In addition, 16 mM Mg did not affect 
inflammatory cytokine production in PBMC (day 4). Therefore, the effects of degradable Mg on 
the production of inflammatory cytokines in mono HUCPV or PBMC cultures were biphasic. 
However, coculture with HUCPV downregulated Mg-induced increased levels of pro-
inflammatory cytokines on day 1 (7 mM Mg) and day 4 (18 mM Mg) individually. Similarly, on 
day 7, HUCPV attenuated the increased secretion of anti-inflammatory cytokines from PBMC 
exposed to 15 mM Mg (colour scale: dark red to light red). These comparisons in cocultures 
revealed the immuno-suppressive role of HUCPV interacting with PBMC under Mg stimulation 
regardless of Mg concentrations. Thus, the interface of the Mg biomaterial-tissue retains a more 
moderate status of inflammation. This finding is consistent with the study on the immuno-
suppressive capacity of MSC wherein MSC regulate the transition from a Th1-driven response 
to an anti-inflammatory Th2 response. This response is characterised by lower concentrations 
of TNFα, IFNγ and IL2 and increased production of IL4, IL5, IL10 and IL13 [259].  
Despite the complexity of cytokine signalling, immunomodulation by MSC is crucial for 
macrophages maturation [223, 252-254]. The maturation of immune cells mainly also focuses 
on the assessment of cell surface markers, especially for macrophages. Cell surface markers 
are variably expressed at different stages of macrophage maturation, so measurement of 
surface markers in cells in response to a material can enable researchers to determine whether 
a material induces cell differentiation/maturation [223]. Activated macrophages differentiate into 
M1 and M2. The CD 86 surface marker is normally used to identify M1 macrophages. Cellular 
surface markers for all M2 phenotypes include CD 163 or CD 206 [256]. Flow cytometry is one 
method used by researchers to evaluate cell surface markers, which allows qualification of 
specific cell types [261]. 
Multiple studies confirmed that MSC induce M2 polarization [84, 102, 106]. Mg influences M2 
macrophage polarization in various microenvironments, as indicated by flow cytometry [262, 
263]. Current results of both transwell coculture and conditioned media system suggested that 
M2 subpopulations increased on day 1 upon coculture with HUCPV. Furthermore, in the 
presence of Mg, M2 subpopulations were dramatically increased in both transwell coculture 
and conditioned media system with or without HUCPV. PGE2 also influenced M2 macrophages 
polarization [264, 265] based on evaluation of prostaglandin E synthase 2 (PTGES2) gene 
expression in HUCPV. PTGES is a key enzyme in the production of PGE2 [266]. As shown in 
Fig. S1 (supplementary data), Mg and/or PBMC upregulated PTGES2 gene expression at day 
7. These results in transwell coculture and conditioned media system conjointly suggest that 
the M2 percentage of macrophages is probably influenced by Mg and that other factors, such 
as cell interactions, are also involved (e.g., PTGES2 expression).  
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Moreover, mediators, such as TNFα, IL1β, IL4, IL10, HGF (hepatocyte growth factor), PGE2 
and IDO (indoleamine 2,3-dioxygenase 1), which are expressed by MSC and released by 
immune cells [267], lead to the activation of immunosuppressive Treg cells [268] to regulate the 
last phase and intensity of inflammation in fracture healing. Thus, higher levels of TNFα and 
IL10 are secreted by PBMC under Mg stimulation for 7 days, and upregulated prostaglandin E 
synthase 2 (PTGES2) gene expression is noted on day 7 (Fig. S1). These findings indicate that 
Mg positively influences the immuno-regulatory role of MSC on PBMC via multiple factors. 
6.2.2.  Migration/wound healing 
During fracture healing, MSC initially migrate to the bone injury site to participate in healing 
before differentiating into osteoblasts-like cells [267, 269-271]. MSC migrate into fracture sites 
to participate in repair of damaged tissue and fracture healing [267, 269-271].  
MSC recruitment is influenced by a series of secretory cytokines, such as MCP-1, MIP-1α/β, 
and IL8 [125, 272]. For instance, MCP-1 acts as a homing factor to recruit macrophages and 
MSC into the sites of bone repair [273, 274]. Other reports also implicate the stimulation of 
MCP-1 on ultimate bone formation by promoting callus formation and accelerating bone 
resorption [275, 276]. In addition, MIP-1α/β contributes to migration of immune cells and 
regulates bone regeneration by controlling the dynamic balance of osteoblasts and osteoclasts 
[277, 278]. IL8 not only enhances therapeutic effects of MSC on bone regeneration but also 
stimulates osteoclasts activity and bone resorption [279, 280]. GM-CSF is also well-known for 
stimulating human MSC mobilization [281]. 
As shown in Fig. S2, cytokines inducing MSC migration, such as IL8, GM-CSF, MCP-1, and 
MIP-1α/β in PBMC, were dramatically upregulated by Mg, especially on days 1 and 7. Thus, 
attempting to further examine the migration potency of HUCPV affected by Mg, an in vitro 
wound healing assay was performed with supernatants collected at day 1 from various transwell 
coculture conditions, including Mg, P, and P+Mg. 
As previously shown in section 5.1.5, compared with α-MEM (Ctr), Mg or PBMC (P) or both 
(P+Mg) significantly stimulated HUCPV migration into the closure area in transwell coculture. 
Similarly, a stimulated migratory distance of HUCPV was observed in P+Mg compared with 
HUCPV in P. The results revealed that HUCPV exhibits an increased capacity to migrate when 
cultured with Mg and/or PBMC for 24 hours. 
In the transwell coculture system, the addition of Mg discs resulted in a concentration-
dependent stimulation of IL8, MCP-1, and MIP-1α/β. Indeed, higher concentrations of Mg (4-
19 mM) upregulated extracellular IL8, MCP-1, and MIP-1α/β levels. Although enhanced 
HUCPV migration was measured in transwell coculture supernatant (4-8 mM Mg), no significant 
migration was observed in conditioned media system groups with Mg concentrations of 0.5-4 
mM. It is therefore reasonable to assume that the effects of Mg on HUCPV migration are 
concentration dependent. To some extent, local Mg2+ concentrations may mediate HUCPV 
migration since the shift of local extracellular Mg2+ and Ca2+ impacts cell-cell and cell-
extracellular matrix interactions during would healing [282]. 
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Therefore, the enhanced migratory ability of HUCPV was not only due to Mg itself (Mg contents) 
but also due to the involvement of Mg-induced paracrine signalling of IL8, GM-CSF, MCP-1, 
and MIP-1α/β. 
6.2.3.  Osteogenic potential of HUCPV 
High ALP activity and specific upregulated pro-osteogenic genes are indicators osteogenic 
differentiation of MSC populations. It is well documented that Mg-based biomaterials enhance 
pro-osteogenic activities of MSC [283, 284]. In addition, evidence supports roles of monocytes 
in upregulating the osteogenic potential of MSC [285].  
Compared with the conditioned media system, the transwell coculture system induces HUCPV 
differentiation towards a pro-calcific phenotype (ALP activity). In the evaluation of osteogenesis 
in the conditioned media system, PBMC-, Mg- or (PBMC+Mg)-conditioned media induced 
increased COL1A1 and OPN gene expression. In the transwell coculture system, Mg alone and 
PBMC+Mg induced various osteogenic parameters in HUCPV, such as increased ALP activity, 
upregulated collagen synthesis, and OC and OPN expression. Due to the more interactive 
communication between HUCPV and PBMC in transwell coculture model, these results 
particularly imply the pro-osteogenic roles of Mg but not PBMC. 
In addition, increased levels of IL12, bFGF, and VEGF are recognized as markers of foetal-
derived osteoblastogenesis [217]. As shown in Fig. S3, Mg elevated the production of bFGF (H 
vs. H+Mg at day 1), VEGF (H vs. H+Mg, or H+P vs. H+P+Mg at day 7), and IL12 (H vs. H+Mg 
at day 7). Interestingly, at days 1 and 4, PBMC significantly reduce production of these three 
cytokines (H vs. H+P or H+Mg vs. H+P+Mg). 
Mg stimulated increased secretions of IL12, bFGF, and VEGF and induced various osteogenic 
parameters, such as ALP activity, collagen synthesis and OC and OPN expression, indicating 
that Mg enhance the osteogenic differentiation of MSC [283, 284]. As reported, monocytes 
enhance osteogenic gene expression in MSC [285] and further promote osteoblast formation 
[165, 166]. Furthermore, it has also been well-documented that macrophages engage in the 
degradation of biomaterials and contribute to the osteogenic behaviour of MSC, which aid in 
bone regeneration [286]. The immune microenvironment can effectively stimulate osteogenesis; 
therefore, the roles of degradable Mg via paracrine secretions in immune-mediated 
osteogenesis will be further studied for longer periods (7 days reflect early osteogenesis). 
6.3.  Mechanisms of macrophage-mediated osteogenic activity of HUCPV 
in direct coculture systems 
Communication between MSC and immune cells induces MSC differentiation into pre-
osteoblasts and subsequently mature osteoblasts. These processes normally occur after MSC 
recruitment until they direct contact with local immune cells or implants.  
The applied direct coculture model clearly showed the improved osteogenic ability of HUCPV 
in the context of Mg, and a more pronounced effect was noted with Mg-10Gd. In detail, both 
materials induced ALP secretion and upregulated expression of specific osteogenic gene (ALP, 
OC, and OPN) on days 7 and 14 compared with control groups. Furthermore, Mg-10Gd was a 
more efficient stimulator than pure Mg. Importantly, such positive regulation of bone-forming 
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differentiation is not only dependent on formerly discussed Mg2+ released by materials but also 
relies on macrophage production of regulatory factors, including inflammatory factors (OSM/IL6, 
TNFα and IL1β) and growth factors (BMP6). 
Summarized results from the direct coculture system are presented in Fig. 44. The possible 
mechanisms of Mg-based material-induced osteogenic differentiation include the following:  
l Stimulatory roles of OSM and gp130; 
l Stimulatory roles of BMP6; 
l Inhibitory roles of TNFα and IL1β. 
 
Fig. 44 Mechanisms of Mg-based material-induced secretion of signalling factors by 
macrophages promoting the osteogenic differentiation of HUCPV in a direct coculture system. 
One method to measure inflammatory cytokines secreted from immune cells, especially 
macrophages, is ELISA. ELISA is a plate-based measurement technique that can quantify 
specific proteins in liquid samples using highly specific antibodies linked to enzymes. Detection 
is achieved by evaluating the activity of the coupled enzyme through colour changes. In the 
current test, ELISA was used to quantify the concentration of inflammatory cytokines from 
macrophages exposed to Mg and Mg-10Gd. Single marker assays include TNFα, IL1β, IL6 and 
OSM. 
The present study also focuses on gene expression of growth factor markers based on immune 
cells’ interactions with biomaterials. A more modern method of gene expression analysis, 
namely RT-qPCR, was used. RT-qPCR [287] uses oligonucleotide probes specifically designed 
to anneal to the target gene sequence to quantify the target DNA amplified from the sample in 
real time. During the amplification process, the probe is cleaved to release specific fluorescent 
labels. In many cycles, gene-specific fluorescence is measured in real time and is proportional 
to the starting amount of each target gene in the template sample. Target gene expression is 
calculated relative to the baseline sample (reference genes). This analysis reduces the 
experiment time, thereby improving the efficiency of biomaterial evaluation. In the current study, 
BMP6 gene expression in response to Mg/Mg-10Gd was analysed. The following cascades 
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related to the BMP/Smad signalling pathway, such as BMPR1A, BMPR2, and Smad 1/4/5/8, 
were also analysed. 
6.3.1.  OSM and gp130 dependency 
OSM, a multifunctional cytokine of the IL6 family, has been implicated in the inflammation and 
bone tissue regeneration. OSM is produced by activated CD 14+ monocytes/macrophages and 
enhances MSC osteogenesis. This stimulation could be inhibited using neutralizing antibodies 
to OSM, OSM receptor (OSMR and gp130), or downstream STAT3 pathway signal transducers 
[166]. Another recent study also demonstrated that the pro-osteogenic differentiation of human 
adipose-derived stem cells was stimulated after OSM pre-treatment [164]. IL6 is secreted by 
immune cells and acts as a pro-inflammatory cytokine, but it is also produced by stromal cells 
to promote osteogenesis [159]. Research indicates that expression of osteogenic genes, such 
as COL1A1 and OPN, is not altered in MC3T3-E1 cells by IL6, but ALP activity is increased by 
IL6 and reduced upon IL6 neutralization [288].  
These lines of evidence collectively consolidate the pro-osteogenic induction of OSM and IL6. 
However, the roles of Mg/Mg-10Gd in OSM/IL6-mediated pro-osteogenic activity are not well 
characterized. Hence, in the present study, OSM production was stimulated in direct cocultures, 
particularly upon exposure to Mg and Mg-10Gd. Secretion of pro-inflammatory IL6 in HUCPV 
monoculture and cocultures was significantly decreased by materials at day 7 but restored after 
an additional 7 days. Meanwhile, a clear difference between HUCPV alone and cocultures 
under Mg stimulation was noted on day 14. The IL6 difference was consistent with the highest 
ALP levels and osteogenic-specific gene expression in HUCPV-macrophage cocultures 
exposed to materials. In addition, anti-human OSM and anti-human gp130 inhibit the functions 
of osteogenic factors (OSM and IL6) and clearly antagonized extracellular ALP activity in 
osteogenic differentiation of HUCPV cocultured with Mg and Mg-10Gd.  
Taken together, the current study highlights that Mg and Mg-10Gd mediate pro-osteogenic 
activity through regulating OSM/IL6, and the process is OSM and gp130 dependent. 
6.3.2.  Stimulatory roles of BMP/Smad signals 
Macrophages have a role in BMP-dependent differentiation of MSC via production of BMPs. 
BMP2 or BMP6 bind to BMP receptors, such as BMPR1 and BMPR2, which subsequently 
activate Smad signalling receptors and increase osteogenic differentiation of MSC.  
In direct contact cocultures, BMP6 upregulation was first demonstrated in macrophages 
exposed to Mg-based materials. BMP proteins induce Smad 1/5/8 phosphorylation. Smad 4 is 
recognized as vital player in the BMP/Smad signalling pathway involved in osteogenic 
differentiation [289, 290]. Increased expression of Smad signalling receptors, such as BMPR1A, 
BMPR2, and Smad 1/4/5/8, was observed in cocultures with Mg and Mg-10Gd compared with 
cocultures without biomaterials (controls).  
BMP2 enhances bioactivity [291, 292] and repair [293] incorporating with Mg-based 
biomaterials. Accordingly, present findings support the hypothesis that macrophages express 
the BMP6 gene, which synergizes with Mg and Mg-10Gd, further regulating the osteogenic 
differentiation of HUCPV via the BMP/Smad signalling pathway. Hence, BMP protein 
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represents a promising mediator of Mg-based biomaterials by enhancing bioactivity and tissue 
repair. 
6.3.3.  Inhibitory roles of TNFα and IL1β 
Increasing evidence suggests that the secretion of macrophages in response to Mg-based 
biomaterials induced profound changes in MSC differentiation.  
In particular, upon exposure to Mg ions or Mg-based materials, macrophages are polarized into 
an anti-inflammatory phenotype termed M2 [263, 294-296]. M2 phenotype macrophages 
secrete less TNFα, IL1β and release higher level of IL10. Furthermore, a dose-dependent, 
negative correlation between TNFα and IL1β production and osteogenic differentiation was 
confirmed [297-299]. In current experiments, a significant decrease in TNFα and IL1β were 
observed in macrophages (-/+HUCPV) when seeded on Mg and Mg-10Gd, supporting the 
hypothesis of anti-inflammatory effects of osteoblastogenesis. Similar results were also shown 
in other studies using a Mg–Ca phosphate cement extract, in which the pro-inflammatory 
cytokines, including TNFα and IL-6, were less expressed in macrophages [80].  
In summary, excessive production of pro-inflammatory cytokines (TNFα and IL1β) could cause 
the loss of implants, whereas suitable concentrations of pro-inflammatory factors (OSM and 
IL6) could synergize to stimulate bone formation. Thus, the balance of pro- and anti-
inflammation is necessary to consider as a feature to evaluate the property of biomaterials. As 
degradable biomaterials, Mg and Mg-10Gd result in enhanced osteogenic differentiation of 
HUCPV based upon the release of osteogenic factors, such as proteins (OSM/IL6) and growth 
factors (BMP6). 
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7. Outlook 
Biomaterial-mediated bone healing involves early inflammation, bone formation and 
remodelling phases. The specific stages include coagulation, immune response, and bone 
formation. The early stage of tissue repair is mainly modulated by an immune response, where 
the majority of monocytes are activated into pro-inflammatory macrophages (phenotype M1). 
The switch pattern of the macrophage phenotype to an anti-inflammatory phenotype (M2) 
occurs in the bone formation phase, resulting in osteogenic-related cytokine secretion to 
manage the formation of new tissue and bone. A continuous M1 phenotype contributes to 
chronic inflammation, whereas excessive M2 induces fibrous encapsulation, which could be 
enhanced by the secreted cytokines and ultimately lead to biomaterial implantation failure. In 
light of unavoidable immune response, a bone substitute material could be designed to utilise 
the crosstalk between immune cells and MSC and consequently improve bone regeneration.  
Based on results from the current study, the outlook for the orthopaedic applications are 
presented from two aspects: 
l Possible strategies for bone substitute materials; 
e.g., modification by incorporating relevant metallic ions or specific cellular mechanisms 
(auto/paracrine signalling; secretions of inflammatory factors and growth factors). 
l Therapeutic potential of utilizing MSC (HUCPV)-macrophages for bone formation. 
e.g., biological therapies (osteo-immunomodulatory properties of MSC) as well as tissue 
engineering approaches stimulating bone regeneration by targeting osteoblastogenesis 
through interactions between MSC and immune cells. 
7.1.  Possible strategies for bone substitute materials 
Bone substitute materials could be improved to modulate the immune response of PBMC, 
macrophages, and lymphocytes; specifically, the surface properties (surface roughness, 
surface wettability and surface charge), particle size, pore size, and ion release properties could 
be improved [300-302]. Hence, based on the results of this study, Mg-based biomaterials could 
be manufactured to form more desired immunomodulation properties based on the following 
methodologies. 
7.1.1.  Modification by incorporation of Ca, Strontium (Sr), and Zn 
The consistent corrosion of materials after implantation is mainly dominated by physiological 
microenvironment and cell-mediated material dissolution. Many metals or inorganic elements 
could be applied to optimize the degradation while controlling the release profile from materials 
that are important in interacting with the microenvironment (Fig. 45). 
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Fig. 45 Common specific targets of relevant metallic ions and their therapeutic roles in the 
human body. The figure is adapted from previous work [303] with permission under the license 
of "CC BY 4.0": https://creativecommons.org/licenses/by/4.0/. 
For instance, Ti coated with Sr-, Mg-, and Si-containing Sr2MgSi2O7 (SMS) ceramics promote 
the anti-inflammatory M2 phenotype and suppress inflammation via inhibiting Wnt family 
member 5A (Wnt5A)/Ca2+ and TLR pathways in macrophages [40]. Additionally, this SMS 
coating maintains comparable osteogenesis and reduces osteoclast activities. Another study 
based on Ti conducted with nutrient element-based bioceramic coatings (Sr2ZnSi2O7 (SZS)) 
reported that coating enhance osteogenic differentiation of bone marrow-MSC but 
downregulate osteoclastogenesis via inhibition of the RANKL (receptor activator of nuclear 
factor kappa-Β ligand)/RANK (receptor activator of nuclear factor kappa-Β) pathway [304]. The 
Ca element was also a potential candidate to decrease M1 polarization and the M2 phenotype 
through the TLR signalling pathway, in which Ca-incorporated implants (Ca11Si4B2O22) improve 
osteogenesis [305].  
Current findings suggest that Mg possesses osteo-immunomodulatory properties. Thus, 
specific metallic elements could be incorporated with Mg to design a bone substitute material 
to achieve improved inflammation and osteogenesis.  
7.1.2.  Functionalization with inflammatory mediators (IL4, IL10 and OSM) and growth 
factors (TGFβ1, BMP and VEGF)  
Many cytokines and large molecules, such as IL4, IL10, and LPS, mediate inflammation via 
influencing immune cell activities. Importantly, these factors cooperate with biomaterials to 
improve clinical outcomes.  
For instance, IL4 delivery by osmotic pumps was reported to induce M2-like phenotype 
polarization from macrophages in vitro [306]. Additionally, the release of such components 
could be controlled by materials to modify inflammation status. The release of components 
(IL4/IL10/TGFβ1) loaded on gelatine/tyraminated films could be controlled to increase tissue 
repair by retaining an anti-inflammatory environment with decreased levels of pro-inflammatory 
cytokines [307]. As documented in the current results, secretory mediators not only regulate 
inflammation but also modulate osteoblastogenesis. OSM carried by an inactive demineralized 
bone matrix (DBM) stimulated osteogenesis in a rabbit model [181]. Importantly, BMP2 and 
BMP7 have been approved for clinical trials in open fractures of long bones, non-unions and 
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spinal fusion [308]. Moreover, BMP2 and VEGF are upregulated in macrophages and MSC 
seeded on Ca-incorporated materials, leading to activation of BMP2 signalling and subsequent 
osteogenic cascades [305]. Other reports also revealed that factors used for coating are 
associated with osteogenic outcomes. For example, scaffolds could be doped with osteogenic-
specific BMP to regulate bone formation [309]. BMP coating on metal implants represents a 
strategy to increase osteogenic differentiation in a dose-dependent manner [182]. Moreover, 
BMP2 incorporation into the coating increases osteoinductive efficacy and attenuates 
inflammation compared with direct absorption on implants [310]. The results of the current study 
suggest that Mg ions potentially could be designed as carriers or scaffolds to achieve good 
performance of fracture healing. Additionally, the coating of cytokines and growth factors (IL4, 
IL10, OSM, TGFβ1, BMP and VEGF etc.) on Mg-based biomaterials could represent a method 
to improve clinical trials of fracture healing. 
7.1.3.  Combinations with anti-inflammatory drugs 
To prevent and even control local inflammation after biomaterial implantation, many 
applications of implantable medical devices have been developed to modulate the release or 
administration of anti-inflammatory drugs.  
For instance, inflammatory IFNγ and TNFα are reduced by local injection of aspirin around the 
stem cell implantation site to markedly improve bone regeneration [311]. The dynamics or 
outcomes of these inflammatory-active agents could be modulated by the properties of 
biomaterials. The release of dexamethasone, an anti-inflammatory medication, could be 
prolonged by microsphere-like materials [312]. The multilayer surface could confer anti-
inflammatory properties of material to monocytes [313].  
These drugs and their targets of interest could be another avenue to develop Mg-based 
biomaterials and regulate in vivo inflammation. In addition, Mg incorporation could increase the 
anti-inflammatory potential of a biomaterial. 
7.2.  Therapeutic potential of utilising MSC (HUCPV)-macrophages for 
bone formation 
Furthermore, current findings regarding the interactions of immune cells and MSC underscore 
the value of Mg in tissue regeneration. MSC have been widely applied in tissue repair in the 
field of regenerative medicine given widely available resources, differentiation potential, and 
immune-modulatory effects on the host microenvironment. In addition, an implant is a crucial 
carrier to act as biotic and abiotic graft scaffold [314]. 
Potential cell-based therapy could also be employed for bone regeneration. More attention has 
focused on either bone-forming MSC or immunoregulatory macrophages. However, minimal 
research has focused on targeting the interaction between MSC and macrophages to stimulate 
bone formation. For instance, MSC has been used for bone regenerative therapy via 
differentiating into endothelium of blood vessels, cartilage, and bone at the site of fracture. 
Regarding macrophages, several methods were optimized to control macrophages for bone 
regenerative applications, such as delivering induced M1 or M2 macrophages into fracture sites 
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and manipulating the number or phenotype of macrophages with recombinant molecules and 
biomaterials [315]. 
Based on previous and current research, two possible methods  to enhance bone 
regeneration through the crosstalk of MSC and macrophages are outlines:  
l To more efficiently attract tissue repair cells (MSC) to into injurious sites, migratory 
molecules (IL8, MCP-1, and MIP-1α/β) could be stimulated or coupled with Mg-based 
materials.  
l To induce macrophages towards a tissue regenerative M2 phenotype, Mg-based 
materials (Mg ions) or agonists/inducing agents of IL4/13 or BMP could be applied. 
Some studies have demonstrated the possibility of stimulating bone formation with these 
bioactive molecules. Wood et al. (2014) investigated the function of MCP-1 to promote wound 
healing in diabetics through restoring the macrophages response [316]. Using a chick 
chorioallantois membrane assay, MCP-1 mediated TGFβ activity in the formation of new blood 
vessels, and this effect could be attenuated by its blocking antibody [317]. MCP-1 and its 
blocking antibody regulated MSC migration [126]. Inflammatory chemotactic agents (IL8/MCP-
1/MIP-1) also attract human MSC in the interface culture of ischemic brain [125]. Engelhardt et 
al. suggested IL8 and MCP-1 contribute to the filtration of leukocytes and thus examined 
inflammation and reparative activities [318]. The current study on the migratory ability of 
HUCPV revealed increased levels of migration-related cytokines (GM-CSF, IL8, MCP-1 and 
MIP-1α/β) in PBMC induced by Mg in transwell coculture, which was accompanied by 
enhanced migratory distances of HUCPV (wound healing assay). These findings indicate that 
Mg could represent a promising strategy to stimulate bone formation.  
Several other studies consolidate such integration between inflammation and bone 
regeneration. For instance, MSC induce the M2 phenotype of macrophage polarization at 
inflammation sites in the mixture of MSC and macrophages [102, 106]. IL4 and/or IL13 induce  
M2-like macrophages in an anti-inflammatory environment [319, 320]. Peroxisome proliferator-
activated receptor gamma (PPARγ), an inducer of inflammation, is activated to upregulate M2-
like macrophages to produce an anti-inflammatory effect [321].  
In addition, materials modulate immunoregulation between tissue healing and inflammation via 
stimulating M2-inducible factors. Therefore, a local anti-inflammation effect could be expected. 
For instance, Bartneck et al. (2015) reported that 3D hydrogel-coated nanofibers induce 
macrophages with tissue-healing properties [322]. The injection of pro-resolution mediators 
resulted in increased numbers of M2 macrophages on the crosslinked chitosan (CH) scaffold 
in vivo using a mouse air-pouch model of inflammation [323]. One study indicated the potential 
for Mg to integrate osteogenesis and macrophage activity via the polarizing M2 phenotype and 
upregulating osteogenic genes, such as BMP2/6 and VEGF, in macrophages [324]. This finding 
is consistent with the results of the current study on the stimulatory roles of Mg in BMP6 
expression-mediated osteoblastogenesis. 
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8. Summary and conclusion 
The dynamic processes of inflammation and bone regeneration in fracture healing are 
dependent on a close interplay between material-induced immune cell behaviours and bone-
forming cell behaviours. Our findings demonstrated that degradable Mg influenced HUCPV-
PBMC/macrophage interactions. The interplay of these cells is based on mediators, such as 
secretory cytokines and microenvironment (Mg concentrations, pH, and osmolality). Mg could 
affect the cells’ behaviour in cooperation with other cell types.  
In the early stage (indirect coculture: transwell coculture and conditioned media system; within 
7 days) of inflammation: 
l Mg collaborated with HUCPV to attenuate inflammation via moderate cytokine release 
accompanied by the induction of the pro-healing M2 macrophage phenotype;  
l Mg synergizes with immune cells (PBMC) to stimulate HUCPV migration; 
l The pro-osteogenic potential of HUCPV could be influenced by Mg but not PBMC. 
Thus, suppressed inflammation and faster bone tissue repair could be expected based on the 
osteo-immunomodulatory properties of degradable Mg.  
In the later stage (direct coculture system; 7-14 days) of inflammation, paracrine secretion from 
macrophages, such as inflammatory cytokines (OSM, IL6, TNFα, and IL1β), and growth factors 
(BMP6) are synergistically involved in Mg- and Mg-10Gd-modulated osteogenic differentiation.  
Taken together, the present findings emphasize the osteo-immunomodulatory properties of Mg. 
Specifically, Mg could create a beneficial immune reaction for pro-osteogenic differentiation of 
MSC; thus, increased bone regenerative formation and injurious tissue healing can be expected. 
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Appendix 
Supplementary data 
Table S1 Levels of secreted cytokines (normalised by total DNA) in supernatants in transwell 
coculture system at day 1, 4 and 7. Data were acquired: Cytokine level (pg/mL)/Total DNA 
contents (μg/mL), and obtained from biological duplicate of three independent experiments 
came from at least two donors of HUCPV (H) and PBMC (P), resulting in n≥12 (samples size). 
<<OOR represents “out of calibration range” in multiplex immunoassay.  
H+
P+
M
g SD
 
10
45
.2
5 
13
.2
8  
8.
24
 
4.
78
 
79
.5
6  
13
.0
9  
9.
43
 
37
2.
40
 
99
86
.0
1 
24
2.
98
 
<<
 O
O
R
 
<<
 O
O
R
 
M
ea
n 
94
7.
88
 
10
.4
4  
4.
43
 
2.
77
 
60
.5
8 
12
.6
6 
6.
23
 
29
6.
49
 
59
36
.3
7 
18
8.
44
 
<<
 O
O
R
 
<<
 O
O
R
 
H+
P 
SD
 
11
27
.6
0 
4.
36
 
4.
09
 
0.
37
 
88
.6
9 
7.
17
 
10
.0
9 
18
.3
6 
28
0.
25
 
62
.2
1  
<<
 O
O
R
 
<<
 O
O
R
 
M
ea
n  
86
7.
51
 
2.
33
 
2.
62
 
0.
31
 
64
.0
3 
9.
17
 
6.
70
 
22
.1
8 
17
6.
26
 
38
.1
1 
<<
 O
O
R
 
<<
 O
O
R
 
P+
M
g S
D 
45
0.
86
 
12
.9
7 
31
.9
6 
4.
12
 
81
.0
6 
44
.1
0 
6.
22
 
12
.7
1 
29
70
2.
55
 
21
8.
41
 
<<
 O
O
R
 
<<
 O
O
R
 
M
ea
n 
32
9.
72
 
19
.7
2 
55
.7
8 
4.
40
 
11
4.
44
 
73
.4
5 
6.
79
 
26
.2
1 
41
22
7.
49
 
25
7.
26
 
<<
 O
O
R
 
<<
 O
O
R
 
P 
SD
 
1.
92
 
2.
61
 
3.
62
 
0.
43
 
4.
31
 
2.
09
 
<<
 O
O
R
 
1.
00
 
41
84
.9
8 
28
.4
3 
<<
 O
O
R
 
<<
 O
O
R
 
M
ea
n 
2.
79
 
1.
70
 
1.
97
 
0.
29
 
2.
65
 
1.
21
 
<<
 O
O
R
 
0.
38
 
33
13
.4
7  
12
.0
4 
<<
 O
O
R
 
<<
 O
O
R
 
H+
M
g  S
D 
20
29
9.
56
 
14
8.
98
 
10
3.
62
 
19
4.
68
 
11
88
.2
7 
88
.6
1 
11
6.
45
 
28
19
.4
2 
63
1.
23
 
99
30
.5
5 
<<
 O
O
R
 
<<
 O
O
R
 
M
ea
n 
15
89
4.
11
 
13
3.
85
 
69
.6
0  
13
8.
26
 
98
5.
20
 
25
7.
37
 
78
.7
7 
31
64
.9
8  
67
9.
66
 
76
86
.9
8  
<<
 O
O
R
 
<<
 O
O
R
 
H 
SD
 
17
10
7.
77
 
55
.4
6 
87
.5
4 
26
.3
8  
17
29
.6
6 
14
6.
55
 
15
1.
06
 
20
2.
45
 
47
5.
68
 
14
25
.6
4 
<<
 O
O
R
 
<<
 O
O
R
 
M
ea
n 
12
98
8.
10
 
34
.0
2 
37
.3
2  
16
.4
5 
11
98
.9
3 
13
2.
51
 
10
0.
78
 
18
2.
53
 
28
8.
33
 
10
70
.2
2 
<<
 O
O
R
 
<<
 O
O
R
 
Da
y 
1  
IL
6  
IL
7  
IL
9  
IL
12
 
IL
15
 
IL
17
 
Eo
ta
xi
n 
FG
Fb
 
IP
10
 
VE
G
F 
PD
G
F-
BB
 
RA
NT
ES
 
Faculty of Engineering, Kiel University 
114 
Table S1 (Continued)  
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Fig. S1 Fold levels of PTGES2 expression of HUCPV in transwell coculture (a) and conditioned 
media system (b) on day 7. The primer sequences for the PTGES2 gene were (upper), 5’-
CTTCCTTTTCCTGGGCTTCG-3’ and (lower), 5’-GAAGACCAGGAAGTGCATCCA-3’. Bars 
represent mean ± SD (n≥12). The significances are represented by asterisks and were obtained 
from post hoc multiple comparisons between each group or to controls in ANOVA (α=0.05, 
***P≤0.001). H: HUCPV; P: PBMC; CM: conditioned media. 
 
Fig. S2 Production of selected cytokines (IL8, GM-CSF, MIP-1α/β, and MCP-1) in P and P+Mg 
at each time point in a transwell coculture system. Bars represent mean ± SD (n≥12). The 
significances between two conditions are represented by asterisks and were obtained from t-
test (α=0.05, *P≤0.05, **P≤0.01 and ***P≤0.001). Here, “n.d.” represents “not detected”. 
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Fig. S3 Selected cytokines (bFGF, VEGF, and IL12) production in H/H+P with and without Mg 
at each time point in the transwell coculture system. Bars represent mean ± SD (n≥12). The 
significances are represented by asterisks and were obtained from post hoc multiple 
comparisons between each group or to controls in ANOVA (α=0.05, *P≤0.05). Here, “n.d.” 
represents “not detected”. H: HUCPV; P: PBMC.  
Faculty of Engineering, Kiel University 
118 
Symbols and abbreviations 
Acronym Definition 
AAS Atomic absorption spectroscopy 
ALP Alkaline phosphatase 
AMS Absorbable metal stents 
ANOVA Analysis of variance 
ATP Adenosine triphosphate 
bFGF Basic fibroblast growth factor 
BMP Bone morphogenetic protein 
BMPR Bone morphogenetic protein receptor 
BMMSC Bone marrow mesenchymal stem cells 
BSA Bovine serum albumin 
B2M B2 microglobulin 
CBF Core-binding factor  
COL1A1 Collagen type I alpha 1 
CLC Cardiotrophin-like cytokine 
CNTF Ciliary neurotrophic factor 
CSC China scholarship council 
M-CSF Macrophage colony-stimulating factor 
G-CSF Granulocyte-colony stimulating factor 
GM-CSF Granulocyte-macrophage colony-stimulating factor 
DBM Demineralized bone matrix 
DNA Deoxyribonucleic acid 
ECM Extracellular matrix 
EDTA Ethylenediaminetetraacetic acid 
ELISA Enzyme-linked immunosorbent assay 
FBGC Foreign body giant cells 
FBR Foreign body reaction 
FBS Foetal bovine serum 
FITC Fluorescein isothiocyanate 
FSC Forward scatter 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
GPI Glycophosphatidylinositol 
HAS Hydroxyapatite scaffolds 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HGF Hepatocyte growth factor 
HLA-DR Human leukocyte antigen-DR isotype 
HRP Horseradish peroxidase 
HUCPV Human umbilical cord perivascular 
IDO Indolamin-2,3-dioxygenase 
IFNγ Interferon gamma 
IL Interleukin 
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IP10 Interferon gamma-induced protein 10 
JAK Janus kinase 
JNK C-Jun N-terminal kinase 
LIFR Leukaemia inhibitory factor receptor 
LPS Lipopolysaccharides 
MCP Monocyte chemoattractant protein 
MCPC Magnesium–calcium phosphate cement 
MEM Minimum essential medium 
MIP Macrophage inflammatory protein 
MSC Mesenchymal stem cell 
NFκB Nuclear factor kappa-light-chain-enhancer of activated B cells 
NMDA N-methyl-d-aspartate 
NTC No template control 
OC Osteocalcin 
OOR Out of range 
OPN Osteopontin 
OSM Oncostatin M 
OSMR Oncostatin M receptor 
PBMC Peripheral blood mononuclear cells 
PBS Phosphate-buffered saline 
PCR Polymerase chain reaction 
PDGF-BB Platelet-derived growth factor-BB 
PGE2 Prostaglandin E2 
PMN Polymorphonuclear leukocytes 
PPARγ Peroxisome proliferator-activated receptor gamma 
PTGES2 Prostaglandin E synthase 2 
PTH Parathyroid hormone 
RANK Receptor activator of nuclear factor kappa-Β 
RANKL Receptor activator of nuclear factor kappa-Β ligand 
RANTES 
Regulated upon activation, normal T cell expressed and presumably 
secreted 
RFU Relative fluorescence unit 
RNA Ribonucleic acid 
ROS Reactive oxygen species 
RPL10 Ribosomal protein L10 
RPMI 1640 Roswell Park Memorial Institute 1640 
SFCA Surfactant-free cellulose acetate 
SMAD Mothers against decapentaplegic homolog 
SMS Sr2MgSi2O7 
SSC Side scatter 
STAT Signal transducer and activator of transcription 
SZS Sr2ZnSi2O7 
TGF Tumour growth factor 
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TH1/2 T helper type 1/2 
TLR Toll-like receptor 
TMB Tetramethylbenzidine 
TNF Tumour necrosis factor 
TRAP Tartrate-resistant acid phosphatase 
Treg Regulatory T cell 
VEGF Vascular endothelial growth factor 
Wnt5A Wnt family member 5A 
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